Colin L. Masters, B MED SCI (HONS), MBBS, MD, FRCPath, FRCPA, FAA - Publications

Affiliations: 
Mental Health Research Institute University of Melbourne, Parkville, Victoria, Australia 
Area:
Alzheimer's disease, amyloid
Website:
http://www.mhri.edu.au/board.htm#director

459 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Dang C, Yassi N, Harrington KD, Xia Y, Lim YY, Ames D, Laws SM, Hickey M, Rainey-Smith S, Sohrabi HR, Doecke JD, Fripp J, Salvado O, Snyder PJ, Weinborn M, ... ... Masters CL, et al. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 566-575. PMID 31909172 DOI: 10.1016/j.dadm.2019.05.005  0.36
2019 Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe C, Villemagne V, Salvado O, ... ... Masters CL, et al. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 31884485 DOI: 10.3233/JAD-191028  0.36
2019 Eratne D, Loi SM, Li QX, Varghese S, McGlade A, Collins S, Masters CL, Velakoulis D, Walterfang M. Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response. The Australian and New Zealand Journal of Psychiatry. 4867419893431. PMID 31823653 DOI: 10.1177/0004867419893431  0.64
2019 Papp KV, Buckley R, Mormino E, Maruff P, Villemagne VL, Masters CL, Johnson KA, Rentz DM, Sperling RA, Amariglio RE. Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31759879 DOI: 10.1016/j.jalz.2019.09.074  0.32
2019 Hata S, Omori C, Kimura A, Saito H, Kimura N, Gupta V, Pedrini S, Hone E, Chatterjee P, Taddei K, Kasuga K, Ikeuchi T, Waragai M, Nishimura M, Hu A, ... ... Masters CL, et al. Decrease in p3-Alcβ37 and p3-Alcβ40, products of Alcadein β generated by γ-secretase cleavages, in aged monkeys and patients with Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 5: 740-750. PMID 31754625 DOI: 10.1016/j.trci.2019.09.015  0.36
2019 Vacher M, Porter T, Villemagne VL, Milicic L, Peretti M, Fowler C, Martins R, Rainey-Smith S, Ames D, Masters CL, Rowe CC, Doecke JD, Laws SM. Validation of a priori candidate Alzheimer's disease SNPs with brain amyloid-beta deposition. Scientific Reports. 9: 17069. PMID 31745181 DOI: 10.1038/s41598-019-53604-5  0.36
2019 Hadoux X, Hui F, Lim JKH, Masters CL, Pébay A, Chevalier S, Ha J, Loi S, Fowler CJ, Rowe C, Villemagne VL, Taylor EN, Fluke C, Soucy JP, Lesage F, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nature Communications. 10: 4227. PMID 31530809 DOI: 10.1038/s41467-019-12242-1  0.32
2019 Burnham SC, Loi SM, Doecke J, Fedyashov V, Dore V, Villemagne VL, Masters CL. The dawn of robust individualised risk models for dementia. The Lancet. Neurology. PMID 31526626 DOI: 10.1016/S1474-4422(19)30353-9  0.32
2019 Baker JE, Bruns L, Hassenstab J, Masters CL, Maruff P, Lim YY. Use of an experimental language acquisition paradigm for standardized neuropsychological assessment of learning: A pilot study in young and older adults. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 31514573 DOI: 10.1080/13803395.2019.1665626  0.32
2019 Huq AJ, Fransquet P, Laws SM, Ryan J, Sebra R, Masters CL, Winship IM, James PA, Lacaze P. Genetic resilience to Alzheimer's disease in APOE ε4 homozygotes: A systematic review. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506248 DOI: 10.1016/j.jalz.2019.05.011  0.32
2019 Xiong C, Luo J, Agboola F, Li Y, Albert M, Johnson SC, Koscik RL, Masters CL, Soldan A, Villemagne VL, Li QX, McDade EM, Fagan AM, Massoumzadeh P, Benzinger T, et al. A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31506247 DOI: 10.1016/j.jalz.2019.06.4955  0.64
2019 Baker JE, Pietrzak RH, Laws SM, Ames D, Villemagne VL, Rowe CC, Masters CL, Maruff P, Lim YY. Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults. Neuropsychology. PMID 31368758 DOI: 10.1037/neu0000561  0.36
2019 Venkatraman VK, Sanderson A, Cox KL, Ellis KA, Steward C, Phal PM, Gorelik A, Sharman MJ, Villemagne VL, Lai M, Cyarto EV, Merkel B, Ames D, Szoeke C, Rowe CC, ... Masters CL, et al. Effect of a 24-month physical activity program on brain changes in older adults at risk of Alzheimer's disease: the AIBL active trial. Neurobiology of Aging. PMID 31324405 DOI: 10.1016/j.neurobiolaging.2019.02.030  0.36
2019 Insel PS, Weiner M, Mackin RS, Mormino E, Lim YY, Stomrud E, Palmqvist S, Masters CL, Maruff PT, Hansson O, Mattsson N. Determining clinically meaningful decline in preclinical Alzheimer disease. Neurology. PMID 31289148 DOI: 10.1212/WNL.0000000000007831  0.32
2019 Eratne D, Loi SM, Walia N, Farrand S, Li QX, Varghese S, Walterfang M, Evans A, Mocellin R, Dhiman K, Gupta V, Malpas CB, Collins S, Masters CL, Velakoulis D. A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists? The Australian and New Zealand Journal of Psychiatry. 4867419857811. PMID 31220922 DOI: 10.1177/0004867419857811  0.64
2019 Taswell C, Donohue C, Mastwyk MT, Louey AG, Giummarra J, Robertson J, Darby DG, Masters CL, Rowe CC. Avoiding methodological bias in studies of amyloid imaging results disclosure. Alzheimer's Research & Therapy. 11: 52. PMID 31159862 DOI: 10.1186/s13195-019-0495-y  0.32
2019 Fazlollahi A, Calamante F, Liang X, Bourgeat P, Raniga P, Dore V, Fripp J, Ames D, Masters CL, Rowe CC, Connelly A, Villemagne VL, Salvado O. Increased cerebral blood flow with increased amyloid burden in the preclinical phase of alzheimer's disease. Journal of Magnetic Resonance Imaging : Jmri. PMID 31145515 DOI: 10.1002/jmri.26810  0.36
2019 Shaw LM, Hansson O, Manuilova E, Masters CL, Doecke JD, Li QX, Rutz S, Widmann M, Leinenbach A, Blennow K. Method comparison study of the Elecsys® β-Amyloid (1-42) CSF assay versus comparator assays and LC-MS/MS. Clinical Biochemistry. PMID 31129181 DOI: 10.1016/j.clinbiochem.2019.05.006  0.64
2019 Doré V, Bullich S, Rowe CC, Bourgeat P, Konate S, Sabri O, Stephens AW, Barthel H, Fripp J, Masters CL, Dinkelborg L, Salvado O, Villemagne VL, De Santi S. Comparison of F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL approaches: Validation against histopathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31101517 DOI: 10.1016/j.jalz.2019.02.005  0.32
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Sohrabi HR, Peretti M, Lim YY, Weinborn M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, et al. val158met is not associated with Aβ-amyloid and ε4 related cognitive decline in cognitively normal older adults. Ibro Reports. 6: 147-152. PMID 31080907 DOI: 10.1016/j.ibror.2019.05.001  0.36
2019 Bransby L, Lim YY, Ames D, Fowler C, Roberston J, Harrington K, Snyder PJ, Villemagne VL, Salvado O, Masters CL, Maruff P. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-10. PMID 30924399 DOI: 10.1080/13803395.2019.1593949  0.36
2019 Soldan A, Pettigrew C, Fagan AM, Schindler SE, Moghekar A, Fowler C, Li QX, Collins SJ, Carlsson C, Asthana S, Masters CL, Johnson S, Morris JC, Albert M, Gross AL. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. PMID 30842300 DOI: 10.1212/WNL.0000000000007248  0.64
2019 Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, ... ... Masters CL, et al. A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease. Science Advances. 5: eaau7220. PMID 30775436 DOI: 10.1126/sciadv.aau7220  0.52
2019 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Klotho allele status is not associated with Aβ and APOE ε4-related cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 76: 162-165. PMID 30716541 DOI: 10.1016/j.neurobiolaging.2018.12.014  0.36
2018 Porter T, Burnham SC, Savage G, Lim YY, Maruff P, Milicic L, Peretti M, Ames D, Masters CL, Martins RN, Rainey-Smith S, Rowe CC, Salvado O, Taddei K, Groth D, et al. A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer's Disease. Frontiers in Aging Neuroscience. 10: 423. PMID 30620773 DOI: 10.3389/fnagi.2018.00423  0.36
2018 Lothian A, Lago L, Mukherjee S, Connor AR, Fowler C, McLean CA, Horne M, Masters CL, Cappai R, Roberts BR. Characterization of the metal status of natively purified alpha-synuclein from human blood, brain tissue, or recombinant sources using size exclusion ICP-MS reveals no significant binding of Cu, Fe or Zn. Metallomics : Integrated Biometal Science. PMID 30465671 DOI: 10.1039/c8mt00223a  0.52
2018 Porter T, Burnham SC, Milicic L, Savage G, Maruff P, Lim YY, Li QX, Ames D, Masters CL, Rainey-Smith S, Rowe CC, Salvado O, Groth D, Verdile G, Villemagne VL, et al. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study. Journal of Alzheimer's Disease : Jad. PMID 30412495 DOI: 10.3233/JAD-180713  0.64
2018 Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, Taddei K, Laws SM, Sohrabi HR, Weinborn M, Ames D, Fowler C, Macaulay SL, Maruff P, Masters CL, et al. Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Translational Psychiatry. 8: 238. PMID 30375373 DOI: 10.1038/s41398-018-0293-5  0.36
2018 Cox KL, Cyarto EV, Ellis KA, Ames D, Desmond P, Phal P, Sharman MJ, Szoeke C, Rowe CC, Masters CL, You E, Burrows S, Lai MMY, Lautenschlager NT. A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study. Journal of Alzheimer's Disease : Jad. PMID 30372680 DOI: 10.3233/JAD-180521  0.36
2018 Joie R, Ayakta N, Seeley WW, Borys E, Boxer AL, DeCarli C, Doré V, Grinberg LT, Huang E, Hwang JH, Ikonomovic MD, Jack C, Jagust WJ, Jin LW, Klunk WE, ... ... Masters CL, et al. Multisite study of the relationships between antemortem [C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30347188 DOI: 10.1016/j.jalz.2018.09.001  0.32
2018 Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith SR, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, ... Masters CL, et al. Superior Memory Reduces 8-year Risk of Mild Cognitive Impairment and Dementia But Not Amyloid β-Associated Cognitive Decline in Older Adults. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 30272115 DOI: 10.1093/arclin/acy078  0.36
2018 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Fox NN, Graff-Radford NR, Levin J, Danek A, ... ... Masters CL, et al. Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30266303 DOI: 10.1016/j.jalz.2018.06.3059  0.36
2018 Dang C, Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Yassi N, Hickey M, Rainey-Smith S, Robertson J, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Rowe CC, ... Masters CL, et al. Relationship Between Amyloid-β Positivity and Progression to Mild Cognitive Impairment or Dementia over 8 Years in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 30149452 DOI: 10.3233/JAD-180507  0.36
2018 Bourgeat P, Doré V, Fripp J, Ames D, Masters CL, Salvado O, Villemagne VL, Rowe CC. Implementing the centiloid transformation for C-PiB and β-amyloid F-PET tracers using CapAIBL. Neuroimage. PMID 30130643 DOI: 10.1016/j.neuroimage.2018.08.044  0.36
2018 Harrington KD, Schembri A, Lim YY, Dang C, Ames D, Hassenstab J, Laws SM, Rainey-Smith S, Robertson J, Rowe CC, Sohrabi HR, Salvado O, Weinborn M, Villemagne VL, Masters CL, et al. Estimates of age-related memory decline are inflated by unrecognized Alzheimer's disease. Neurobiology of Aging. 70: 170-179. PMID 30015036 DOI: 10.1016/j.neurobiolaging.2018.06.005  0.36
2018 Lim YY, Hassenstab J, Goate A, Fagan AM, Benzinger TLS, Cruchaga C, McDade E, Chhatwal J, Levin J, Farlow MR, Graff-Radford NR, Laske C, Masters CL, Salloway S, Schofield P, et al. Effect of BDNFVal66Met on disease markers in dominantly inherited AD. Annals of Neurology. PMID 30014553 DOI: 10.1002/ana.25299  0.32
2018 Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Author Correction: Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature Reviews. Neurology. PMID 29880829 DOI: 10.1038/s41582-018-0021-z  0.32
2018 Buckley RF, Mormino EC, Amariglio RE, Properzi MJ, Rabin JS, Lim YY, Papp KV, Jacobs HIL, Burnham S, Hanseeuw BJ, Doré V, Dobson A, Masters CL, Waller M, Rowe CC, et al. Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29803541 DOI: 10.1016/j.jalz.2018.04.010  0.32
2018 Weinborn M, Bucks RS, Sohrabi HR, Rainey-Smith SR, Brown BM, Gardener SL, Gozt A, Christensen D, Savage G, Laws SM, Taddei K, Maruff P, Robertson JS, Ellis KA, Ames D, ... Masters CL, et al. Trajectories of irregular word reading ability as a proxy for premorbid intelligence in Alzheimer's disease, mild cognitive impairment, and healthy aging: A longitudinal study. Psychological Assessment. PMID 29781669 DOI: 10.1037/pas0000565  0.36
2018 Brown BM, Rainey-Smith SR, Dore V, Peiffer JJ, Burnham SC, Laws SM, Taddei K, Ames D, Masters CL, Rowe CC, Martins RN, Villemagne VL. Self-Reported Physical Activity is Associated with Tau Burden Measured by Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 29758940 DOI: 10.3233/JAD-170998  0.36
2018 Lee S, Zimmerman ME, Narkhede A, Nasrabady SE, Tosto G, Meier IB, Benzinger TLS, Marcus DS, Fagan AM, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. Plos One. 13: e0195838. PMID 29742105 DOI: 10.1371/journal.pone.0195838  0.36
2018 Martins RN, Villemagne V, Sohrabi HR, Chatterjee P, Shah TM, Verdile G, Fraser P, Taddei K, Gupta VB, Rainey-Smith SR, Hone E, Pedrini S, Lim WL, Martins I, Frost S, ... ... Masters CL, et al. Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies. Journal of Alzheimer's Disease : Jad. 62: 965-992. PMID 29562546 DOI: 10.3233/JAD-171145  0.52
2018 Bradfield NI, Ellis KA, Savage G, Maruff P, Burnham S, Darby D, Lautenschlager NT, Martins RN, Masters CL, Rainey-Smith SR, Robertson J, Rowe C, Woodward M, Ames D. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years. Alzheimer Disease and Associated Disorders. PMID 29561277 DOI: 10.1097/WAD.0000000000000252  0.36
2018 Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, ... ... Masters CL, et al. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain : a Journal of Neurology. PMID 29522171 DOI: 10.1093/brain/awy053  0.36
2018 Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, Brown BM, Porter T, Weinborn M, Bucks RS, Milicic L, Sohrabi HR, Taddei K, Ames D, Maruff P, Masters CL, Rowe CC, Salvado O, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden. Translational Psychiatry. 8: 47. PMID 29479071 DOI: 10.1038/s41398-018-0094-x  0.36
2018 Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions. Nature Reviews. Neurology. PMID 29449700 DOI: 10.1038/nrneurol.2018.9  0.32
2018 Li QX, Varghese S, Sarros S, Stehmann C, Doecke JD, Fowler CJ, Masters CL, Collins SJ. CSF Tau supplements 14-3-3 protein detection for sporadic Creutzfeldt-Jakob disease diagnosis while transitioning to next generation diagnostics. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. PMID 29422367 DOI: 10.1016/j.jocn.2018.01.064  0.64
2018 Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, ... ... Masters CL, et al. High performance plasma amyloid-β biomarkers for Alzheimer's disease. Nature. 554: 249-254. PMID 29420472 DOI: 10.1038/nature25456  0.64
2018 Porter T, Burnham SC, Doré V, Savage G, Bourgeat P, Begemann K, Milicic L, Ames D, Bush AI, Maruff P, Masters CL, Rowe CC, Rainey-Smith S, Martins RN, Groth D, et al. KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden. Scientific Reports. 8: 2034. PMID 29391469 DOI: 10.1038/s41598-018-20513-y  0.52
2018 Fernando WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, Burnham SC, Macaulay SL, Brown BM, Gupta VB, Sohrabi HR, Weinborn M, Taddei K, Laws SM, Goozee K, Ames D, Fowler C, ... ... Masters CL, et al. Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β. Journal of Alzheimer's Disease : Jad. 61: 1589-1598. PMID 29376865 DOI: 10.3233/JAD-170742  0.36
2018 Lim YY, Kalinowski P, Pietrzak RH, Laws SM, Burnham SC, Ames D, Villemagne VL, Fowler CJ, Rainey-Smith SR, Martins RN, Rowe CC, Masters CL, Maruff PT. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease. Jama Neurology. PMID 29356823 DOI: 10.1001/jamaneurol.2017.4325  0.36
2018 Perin S, Harrington KD, Lim YY, Ellis K, Ames D, Pietrzak RH, Schembri A, Rainey-Smith S, Salvado O, Laws SM, Martins RN, Villemagne VL, Rowe CC, Masters CL, Maruff P, et al. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease. Journal of Affective Disorders. 229: 269-274. PMID 29329059 DOI: 10.1016/j.jad.2017.12.101  0.36
2017 Pietrzak RH, Laws SM, Lim YY, Bender SJ, Porter T, Doecke J, Ames D, Fowler C, Masters CL, Milicic L, Rainey-Smith S, Villemagne VL, Rowe CC, Martins RN, Maruff P, et al. Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort Study. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2: 45-52. PMID 29560886 DOI: 10.1016/j.bpsc.2016.08.006  0.36
2017 Villemagne VL, Rowe CC, Barnham KJ, Cherny R, Woodward M, Bozinosvski S, Salvado O, Bourgeat P, Perez K, Fowler C, Rembach A, Maruff P, Ritchie C, Tanzi R, Masters CL. A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study. Alzheimer's & Dementia (New York, N. Y.). 3: 622-635. PMID 29201996 DOI: 10.1016/j.trci.2017.10.001  0.48
2017 Doecke JD, Rembach A, Villemagne VL, Varghese S, Rainey-Smith S, Sarros S, Evered LA, Fowler CJ, Pertile KK, Rumble RL, Trounson B, Taddei K, Laws SM, Macaulay SL, Bush AI, ... ... Masters CL, et al. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms. Journal of Alzheimer's Disease : Jad. PMID 29171991 DOI: 10.3233/JAD-170128  0.64
2017 Pedrini S, Gupta VB, Hone E, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort. Scientific Reports. 7: 14057. PMID 29070909 DOI: 10.1038/s41598-017-14020-9  0.52
2017 Fandos N, Pérez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, Doecke J, Fowler C, Masters CL, Sarasa M. Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 179-187. PMID 28948206 DOI: 10.1016/j.dadm.2017.07.004  0.32
2017 Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, et al. Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline. Brain : a Journal of Neurology. 140: 2112-2119. PMID 28899019 DOI: 10.1093/brain/awx137  0.52
2017 Frost S, Robinson L, Rowe CC, Ames D, Masters CL, Taddei K, Rainey-Smith SR, Martins RN, Kanagasingam Y. Evaluation of Cholinergic Deficiency in Preclinical Alzheimer's Disease Using Pupillometry. Journal of Ophthalmology. 2017: 7935406. PMID 28894607 DOI: 10.1155/2017/7935406  0.36
2017 Laws SM, Gaskin S, Woodfield A, Srikanth V, Bruce D, Fraser PE, Porter T, Newsholme P, Wijesekara N, Burnham S, Doré V, Li QX, Maruff P, Masters CL, Rainey-Smith S, et al. Insulin resistance is associated with reductions in specific cognitive domains and increases in CSF tau in cognitively normal adults. Scientific Reports. 7: 9766. PMID 28852028 DOI: 10.1038/s41598-017-09577-4  0.64
2017 Vella LJ, Scicluna BJ, Cheng L, Bawden EG, Masters CL, Ang CS, Willamson N, McLean C, Barnham KJ, Hill AF. A rigorous method to enrich for exosomes from brain tissue. Journal of Extracellular Vesicles. 6: 1348885. PMID 28804598 DOI: 10.1080/20013078.2017.1348885  0.48
2017 Harrington KD, Lim YY, Ames D, Hassenstab J, Laws SM, Martins RN, Rainey-Smith S, Robertson J, Rowe CC, Salvado O, Doré V, Villemagne VL, Snyder PJ, Masters CL, Maruff P. Amyloid β-associated cognitive decline in the absence of clinical disease progression and systemic illness. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 156-164. PMID 28761926 DOI: 10.1016/j.dadm.2017.05.006  0.36
2017 Kinnunen KM, Cash DM, Poole T, Frost C, Benzinger TLS, Ahsan RL, Leung KK, Cardoso MJ, Modat M, Malone IB, Morris JC, Bateman RJ, Marcus DS, Goate A, Salloway S, ... ... Masters CL, et al. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28738187 DOI: 10.1016/j.jalz.2017.06.2268  0.36
2017 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Fowler C, Ellis K, Martins RN, Salvado O, Doré V, Villemagne VL, Rowe CC, Laws SM, Masters CL, et al. Trajectories of depressive and anxiety symptoms in older adults: a 6-year prospective cohort study. International Journal of Geriatric Psychiatry. PMID 28736899 DOI: 10.1002/gps.4761  0.36
2017 Lim YY, Rainey-Smith S, Lim Y, Laws SM, Gupta V, Porter T, Bourgeat P, Ames D, Fowler C, Salvado O, Villemagne VL, Rowe CC, Masters CL, Zhou XF, Martins RN, et al. BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF. International Psychogeriatrics. 1-10. PMID 28720165 DOI: 10.1017/S1041610217001284  0.36
2017 Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, et al. The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease. Acta Neuropathologica Communications. 5: 53. PMID 28659169 DOI: 10.1186/s40478-017-0456-2  0.52
2017 Rowe CC, Doré V, Jones G, Baxendale D, Mulligan RS, Bullich S, Stephens AW, De Santi S, Masters CL, Dinkelborg L, Villemagne VL. (18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28643043 DOI: 10.1007/s00259-017-3749-6  0.32
2017 Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P. Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals. Journal of Alzheimer's Disease : Jad. PMID 28550258 DOI: 10.3233/JAD-170072  0.36
2017 Gupta VB, Hone E, Pedrini S, Doecke J, O'Bryant S, James I, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Martins RN. Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort. Alzheimer's & Dementia (Amsterdam, Netherlands). 8: 60-72. PMID 28508031 DOI: 10.1016/j.dadm.2017.04.003  0.52
2017 Brown BM, Sohrabi HR, Taddei K, Gardener SL, Rainey-Smith SR, Peiffer JJ, Xiong C, Fagan AM, Benzinger T, Buckles V, Erickson KI, Clarnette R, Shah T, Masters CL, Weiner M, et al. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28501451 DOI: 10.1016/j.jalz.2017.03.008  0.36
2017 Rita Cardoso B, Hare DJ, Lind M, McLean CA, Volitakis I, Laws SM, Masters CL, Bush AI, Roberts BR. The APOE ε4 allele is associated with lower selenium levels in the brain: implications in Alzheimer's disease. Acs Chemical Neuroscience. PMID 28453930 DOI: 10.1021/acschemneuro.7b00014  0.52
2017 Mukherjee S, Kapp EA, Lothian A, Roberts AM, Vasilev Y, Boughton B, Barnham KJ, Kok WM, Hutton CA, Masters CL, Bush A, Beckman JS, Dey SG, Roberts BR. Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry. Analytical Chemistry. PMID 28453255 DOI: 10.1021/acs.analchem.7b00941  0.52
2017 Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, ... ... Masters CL, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Scientific Reports. 7: 1225. PMID 28450713 DOI: 10.1038/s41598-017-01327-w  0.36
2017 Gardener SL, Rainey-Smith SR, Sohrabi HR, Weinborn M, Verdile G, Fernando WM, Lim YY, Harrington K, Burnham S, Taddei K, Masters CL, Macaulay SL, Rowe CC, Ames D, Maruff P, et al. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner. Journal of Alzheimer's Disease : Jad. PMID 28387666 DOI: 10.3233/JAD-161158  0.36
2017 Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li QX, Ryan TM, McLean CA, Doecke JD, Rowe CC, Villemagne VL, Masters CL. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. Brain : a Journal of Neurology. PMID 28383676 DOI: 10.1093/brain/awx057  0.64
2017 Baker JE, Lim YY, Pietrzak RH, Hassenstab J, Snyder PJ, Masters CL, Maruff P. Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 108-121. PMID 28239636 DOI: 10.1016/j.dadm.2016.09.002  0.32
2017 Hollands S, Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Harrington K, Porter T, Snyder P, Ames D, Fowler C, Rainey-Smith SR, Martins RN, Salvado O, Robertson J, Rowe CC, ... Masters CL, et al. APOEɛ4 Genotype, Amyloid, and Clinical Disease Progression in Cognitively Normal Older Adults. Journal of Alzheimer's Disease : Jad. PMID 28234254 DOI: 10.3233/JAD-161019  0.36
2017 Cardoso BR, Hare DJ, Bush AI, Li QX, Fowler CJ, Masters CL, Martins RN, Ganio K, Lothian A, Mukherjee S, Kapp EA, Roberts BR. Selenium Levels in Serum, Red Blood Cells, and Cerebrospinal Fluid of Alzheimer's Disease Patients: A Report from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL). Journal of Alzheimer's Disease : Jad. PMID 28222503 DOI: 10.3233/JAD-160622  0.64
2017 Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, ... ... Masters CL, et al. A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 56: 1159-1174. PMID 28157104 DOI: 10.3233/JAD-161097  0.72
2017 Peters KE, Davis WA, Taddei K, Martins RN, Masters CL, Davis TM, Bruce DG. Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study. Journal of Alzheimer's Disease : Jad. PMID 28106562 DOI: 10.3233/JAD-161050  0.36
2017 Villemagne VL, Doré V, Bourgeat P, Burnham SC, Laws S, Salvado O, Masters CL, Rowe CC. Aβ-amyloid and Tau Imaging in Dementia. Seminars in Nuclear Medicine. 47: 75-88. PMID 27987560 DOI: 10.1053/j.semnuclmed.2016.09.006  0.32
2016 Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia: update to December 2015. Communicable Diseases Intelligence Quarterly Report. 40: E368-E376. PMID 28278413  0.44
2016 Sabbagh MN, Schäuble B, Anand K, Richards D, Murayama S, Akatsu H, Takao M, Rowe CC, Masters CL, Barthel H, Gertz HJ, Peters O, Rasgon N, Jovalekic A, Sabri O, et al. Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27983552 DOI: 10.3233/JAD-160821  0.32
2016 Harrington KD, Lim YY, Ames D, Hassenstab J, Rainey-Smith S, Robertson J, Salvado O, Masters CL, Maruff P. Using Robust Normative Data to Investigate the Neuropsychology of Cognitive Aging. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. PMID 27932344 DOI: 10.1093/arclin/acw106  0.36
2016 Roberts BR, Doecke JD, Rembach A, Yévenes LF, Fowler CJ, McLean CA, Lind M, Volitakis I, Masters CL, Bush AI, Hare DJ. Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid. Acta Neuropathologica Communications. 4: 119. PMID 27842602 DOI: 10.1186/s40478-016-0390-8  0.52
2016 Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, ... ... Masters CL, et al. Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 27777020 DOI: 10.1016/S1474-4422(16)30229-0  0.36
2016 Holmes SE, Esterlis I, Mazure CM, Lim YY, Ames D, Rainey-Smith S, Martins RN, Salvado O, Dore V, Villemagne VL, Rowe CC, Laws SM, Masters CL, Maruff P, Pietrzak RH, et al. β-Amyloid, APOE and BDNF Genotype, and Depressive and Anxiety Symptoms in Cognitively Normal Older Women and Men. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 27742526 DOI: 10.1016/j.jagp.2016.08.007  0.36
2016 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Bourgeat P, Martins RN, Salvado O, Rowe CC, Masters CL, Maruff P. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Journal of Molecular Neuroscience : Mn. PMID 27586003 DOI: 10.1007/s12031-016-0822-8  1
2016 Cerin E, Rainey-Smith SR, Ames D, Lautenschlager NT, Macaulay SL, Fowler C, Robertson JS, Rowe CC, Maruff P, Martins RN, Masters CL, Ellis KA. Associations of neighborhood environment with brain imaging outcomes in the AIBL cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 27546307 DOI: 10.1016/j.jalz.2016.06.2364  0.36
2016 Burnham SC, Rowe CC, Baker D, Bush AI, Doecke JD, Faux NG, Laws SM, Martins RN, Maruff P, Macaulay SL, Rainey-Smith S, Savage G, Ames D, Masters CL, Wilson W, et al. Predicting Alzheimer disease from a blood-based biomarker profile: A 54-month follow-up. Neurology. PMID 27534714 DOI: 10.1212/WNL.0000000000003094  1
2016 Lim YY, Hassenstab J, Cruchaga C, Goate A, Fagan AM, Benzinger TL, Maruff P, Snyder PJ, Masters CL, Allegri R, Chhatwal J, Farlow MR, Graff-Radford NR, Laske C, Levin J, et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease. Brain : a Journal of Neurology. PMID 27521573 DOI: 10.1093/brain/aww200  1
2016 Buckley RF, Villemagne VL, Masters CL, Ellis KA, Rowe CC, Johnson K, Sperling R, Amariglio R. A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease. Journal of Molecular Neuroscience : Mn. PMID 27514526 DOI: 10.1007/s12031-016-0810-z  0.36
2016 Heffernan AL, Chidgey C, Peng P, Masters CL, Roberts BR. The Neurobiology and Age-Related Prevalence of the ε4 Allele of Apolipoprotein E in Alzheimer's Disease Cohorts. Journal of Molecular Neuroscience : Mn. PMID 27498201 DOI: 10.1007/s12031-016-0804-x  1
2016 Burnham SC, Bourgeat P, Doré V, Savage G, Brown B, Laws S, Maruff P, Salvado O, Ames D, Martins RN, Masters CL, Rowe CC, Villemagne VL. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study. The Lancet. Neurology. PMID 27450471 DOI: 10.1016/S1474-4422(16)30125-9  1
2016 Gu BJ, Huang X, Ou A, Rembach A, Fowler C, Avula PK, Horton A, Doecke JD, Villemagne VL, Macaulay SL, Maruff P, Fletcher EL, Guymer R, Wiley JS, Masters CL, et al. Innate phagocytosis by peripheral blood monocytes is altered in Alzheimer's disease. Acta Neuropathologica. PMID 27411339 DOI: 10.1007/s00401-016-1596-3  0.48
2016 Muenchhoff J, Poljak A, Thalamuthu A, Gupta VB, Chatterjee P, Raftery M, Masters CL, Morris JC, Bateman RJ, Fagan AM, Martins RN, Sachdev PS. Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease. Scientific Reports. 6: 29078. PMID 27381087 DOI: 10.1038/srep29078  1
2016 Chételat G, Ossenkoppele R, Villemagne VL, Perrotin A, Landeau B, Mézenge F, Jagust WJ, Dore V, Miller BL, Egret S, Seeley WW, van der Flier WM, La Joie R, Ames D, van Berckel BN, ... ... Masters CL, et al. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease. Brain : a Journal of Neurology. PMID 27357349 DOI: 10.1093/brain/aww159  0.36
2016 Frost S, Guymer R, Aung KZ, Macaulay SL, Sohrabi HR, Bourgeat P, Salvado O, Rowe CC, Ames D, Masters CL, Martins RN, Kanagasingam Y, Group AT. Alzheimer`s disease and the early signs of age-related macular degeneration. Current Alzheimer Research. PMID 27335042  0.36
2016 Albrecht MA, Masters CL, Ames D, Foster JK. Impact of Mild Head Injury on Neuropsychological Performance in Healthy Older Adults: Longitudinal Assessment in the AIBL Cohort. Frontiers in Aging Neuroscience. 8: 105. PMID 27242516 DOI: 10.3389/fnagi.2016.00105  1
2016 Gupta VB, Doecke JD, Hone E, Pedrini S, Laws SM, Thambisetty M, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Macaulay SL, Rembach A, Rainey-Smith SR, Martins RN, et al. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer's & Dementia (Amsterdam, Netherlands). 3: 18-26. PMID 27239546 DOI: 10.1016/j.dadm.2015.12.001  0.52
2016 Lim YY, Snyder PJ, Pietrzak RH, Ukiqi A, Villemagne VL, Ames D, Salvado O, Bourgeat P, Martins RN, Masters CL, Rowe CC, Maruff P. Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 19-26. PMID 27239532 DOI: 10.1016/j.dadm.2015.11.003  0.36
2016 Hare DJ, Raven EP, Roberts BR, Bogeski M, Portbury SD, McLean CA, Masters CL, Connor JR, Bush AI, Crouch PJ, Doble PA. Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and grey matter iron distribution in Alzheimer's disease frontal cortex. Neuroimage. PMID 27233149 DOI: 10.1016/j.neuroimage.2016.05.057  1
2016 Harrington KD, Gould E, Lim YY, Ames D, Pietrzak RH, Rembach A, Rainey-Smith S, Martins RN, Salvado O, Villemagne VL, Rowe CC, Masters CL, Maruff P. Amyloid burden and incident depressive symptoms in cognitively normal older adults. International Journal of Geriatric Psychiatry. PMID 27114112 DOI: 10.1002/gps.4489  1
2016 Brown BM, Rainey-Smith SR, Villemagne VL, Weinborn M, Bucks RS, Sohrabi HR, Laws SM, Taddei K, Macaulay SL, Ames D, Fowler C, Maruff P, Masters CL, Rowe CC, Martins RN, et al. The Relationship between Sleep Quality and Brain Amyloid Burden. Sleep. PMID 27091528  0.36
2016 Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease. Neurology. PMID 27029632 DOI: 10.1212/WNL.0000000000002604  1
2016 Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, ... ... Masters CL, et al. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the Dominantly Inherited Alzheimer Network. Annals of Neurology. PMID 27016429 DOI: 10.1002/ana.24647  1
2016 Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, ... ... Masters CL, et al. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. Plos One. 11: e0152082. PMID 27010959 DOI: 10.1371/journal.pone.0152082  1
2016 François M, Fenech MF, Thomas P, Hor M, Rembach A, Martins RN, Rainey-Smith SR, Masters CL, Ames D, Rowe CC, Lance Macaulay S, Hill AF, Leifert WR, The Australian Imaging Biomarkers And Lifestyle Study Research Group. High content, multi-parameter analyses in buccal cells to identify Alzheimer's disease. Current Alzheimer Research. PMID 26975368  0.36
2016 Buckley RF, Maruff P, Ames D, Bourgeat P, Martins RN, Masters CL, Rainey-Smith S, Lautenschlager N, Rowe CC, Savage G, Villemagne VL, Ellis KA. Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26852195 DOI: 10.1016/j.jalz.2015.12.013  1
2016 Ryan TM, Griffin MD, McGillivray DJ, Knott RB, Wood K, Masters CL, Kirby N, Curtain CC. Apolipoprotein C-II Adopts Distinct Structures in Complex with Micellar and Submicellar Forms of the Amyloid-Inhibiting Lipid-Mimetic Dodecylphosphocholine. Biophysical Journal. 110: 85-94. PMID 26745412 DOI: 10.1016/j.bpj.2015.11.007  0.32
2015 Kerestes R, Phal PM, Steward C, Moffat BA, Salinas S, Cox KL, Ellis KA, Cyarto EV, Ames D, Martins RN, Masters CL, Rowe CC, Sharman MJ, Salvado O, Szoeke C, et al. Alterations in dorsal and ventral posterior cingulate connectivity in APOE ε4 carriers at risk of Alzheimer's disease. Bjpsych Open. 1: 139-148. PMID 27703739 DOI: 10.1192/bjpo.bp.115.001339  0.36
2015 Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer's disease. Nature Reviews. Disease Primers. 1: 15056. PMID 27188934 DOI: 10.1038/nrdp.2015.56  0.32
2015 Gunn AP, Wong BX, Johanssen T, Griffith JC, Masters CL, Bush AI, Barnham KJ, Duce JA, Cherny RA. Amyloid-Beta Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization and Calcium-Influx in Neurons. The Journal of Biological Chemistry. PMID 26697885 DOI: 10.1074/jbc.M115.655183  0.52
2015 Zwan MD, Villemagne VL, Doré V, Buckley R, Bourgeat P, Veljanoski R, Salvado O, Williams R, Margison L, Rembach A, Macaulay SL, Martins R, Ames D, van der Flier WM, Ellis KA, ... ... Masters CL, et al. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden. Journal of Alzheimer's Disease : Jad. PMID 26639956 DOI: 10.3233/JAD-150446  1
2015 Rembach A, Evered LA, Li QX, Nash T, Vidaurre L, Fowler CJ, Pertile KK, Rumble RL, Trounson BO, Maher S, Mooney F, Farrow M, Taddei K, Rainey-Smith S, Laws SM, ... ... Masters CL, et al. Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology. Alzheimer's Research & Therapy. 7: 71. PMID 26581886 DOI: 10.1186/s13195-015-0157-7  1
2015 Buckley R, Saling M, Ellis K, Rowe C, Maruff P, Macaulay LS, Martins R, Masters C, Savage G, Rainey-Smith S, Rembach A, Ames D. Self and informant memory concerns align in healthy memory complainers and in early stages of mild cognitive impairment but separate with increasing cognitive impairment. Age and Ageing. 44: 1012-9. PMID 26452663 DOI: 10.1093/ageing/afv136  1
2015 Thai C, Lim YY, Villemagne VL, Laws SM, Ames D, Ellis KA, Rainey-Smith SR, Martins RN, Masters CL, Rowe CC, Maruff P. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months. Plos One. 10: e0139082. PMID 26430784 DOI: 10.1371/journal.pone.0139082  1
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study. Journal of Alzheimer's Disease : Jad. 46: 1079-89. PMID 26402634 DOI: 10.3233/JAD-143015  0.36
2015 Leifert WR, Nguyen T, Rembach A, Martins R, Rainey-Smith S, Masters CL, Ames D, Rowe CC, Macaulay SL, François M, Fenech MF. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk. Journal of Alzheimer's Disease : Jad. 48: 443-52. PMID 26402008 DOI: 10.3233/JAD-150330  1
2015 Li QX, Villemagne VL, Doecke JD, Rembach A, Sarros S, Varghese S, McGlade A, Laughton KM, Pertile KK, Fowler CJ, Rumble RL, Trounson BO, Taddei K, Rainey-Smith SR, Laws SM, ... ... Masters CL, et al. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Alzheimer's Disease : Jad. 48: 175-87. PMID 26401938 DOI: 10.3233/JAD-150247  1
2015 Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, et al. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1. Journal of Alzheimer's Disease : Jad. 47: 815-43. PMID 26401762 DOI: 10.3233/JAD-150136  1
2015 Gardener SL, Rainey-Smith SR, Macaulay SL, Taddei K, Rembach A, Maruff P, Ellis KA, Masters CL, Rowe CC, Ames D, Keogh JB, Martins RN. Comparative analysis of the Cancer Council of Victoria and the online Commonwealth Scientific and Industrial Research Organisation FFQ. The British Journal of Nutrition. 114: 1683-93. PMID 26382226 DOI: 10.1017/S0007114515003335  1
2015 Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 862-73. PMID 26260389 DOI: 10.1007/s13311-015-0378-2  0.64
2015 Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, ... ... Masters CL, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/WNL.0000000000001903  1
2015 Merkel B, Steward C, Vivash L, Malpas CB, Phal P, Moffat BA, Cox KL, Ellis KA, Ames DJ, Cyarto EV, Lai MM, Sharman MJ, Szoeke C, Masters CL, Lautenschlager NT, et al. Semi-automated hippocampal segmentation in people with cognitive impairment using an age appropriate template for registration. Journal of Magnetic Resonance Imaging : Jmri. PMID 26140584 DOI: 10.1002/jmri.24966  1
2015 Albrecht MA, Szoeke C, Maruff P, Savage G, Lautenschlager NT, Ellis KA, Taddei K, Martins R, Masters CL, Ames D, Foster JK. Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status. Neuropsychologia. 75: 411-419. PMID 26102189 DOI: 10.1016/j.neuropsychologia.2015.06.008  0.32
2015 Gupta VB, Wilson AC, Burnham S, Hone E, Pedrini S, Laws SM, Lim WL, Rembach A, Rainey-Smith S, Ames D, Cobiac L, Macaulay SL, Masters CL, Rowe CC, Bush AI, et al. Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer's Research & Therapy. 7: 16. PMID 25859282 DOI: 10.1186/s13195-015-0105-6  1
2015 Ellett LJ, Coleman BM, Shambrook MC, Johanssen VA, Collins SJ, Masters CL, Hill AF, Lawson VA. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates. Glycobiology. 25: 745-55. PMID 25701659 DOI: 10.1093/glycob/cwv014  1
2015 Ryan TM, Roberts BR, McColl G, Hare DJ, Doble PA, Li QX, Lind M, Roberts AM, Mertens HD, Kirby N, Pham CL, Hinds MG, Adlard PA, Barnham KJ, Curtain CC, ... Masters CL, et al. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 35: 2871-84. PMID 25698727 DOI: 10.1523/JNEUROSCI.2912-14.2015  0.32
2015 Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, et al. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network. Brain : a Journal of Neurology. 138: 1036-45. PMID 25688083 DOI: 10.1093/brain/awv004  0.32
2015 Ryan TM, Kirby N, Mertens HD, Roberts B, Barnham KJ, Cappai R, Pham Cle L, Masters CL, Curtain CC. Small angle X-ray scattering analysis of Cu(2+)-induced oligomers of the Alzheimer's amyloid β peptide. Metallomics : Integrated Biometal Science. 7: 536-43. PMID 25687761 DOI: 10.1039/c4mt00323c  0.32
2015 Buckley RF, Ellis KA, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Villemagne VL, Macaulay SL, Szoeke C, Martins RN, Masters CL, Savage G, Rainey-Smith SR, Rembach A, Saling MM, et al. Phenomenological characterization of memory complaints in preclinical and prodromal Alzheimer's disease. Neuropsychology. 29: 571-81. PMID 25664464 DOI: 10.1037/neu0000156  0.32
2015 Pietrzak RH, Lim YY, Neumeister A, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Restrepo C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study. Jama Psychiatry. 72: 284-91. PMID 25629787 DOI: 10.1001/jamapsychiatry.2014.2476  0.32
2015 Monserrate AE, Ryman DC, Ma S, Xiong C, Noble JM, Ringman JM, Morris JC, Danek A, Müller-Sarnowski F, Clifford DB, McDade EM, Brooks WS, Darby DG, Masters CL, Weston PS, et al. Factors associated with the onset and persistence of post-lumbar puncture headache. Jama Neurology. 72: 325-32. PMID 25622095 DOI: 10.1001/jamaneurol.2014.3974  0.32
2015 Rembach A, Stingo FC, Peterson C, Vannucci M, Do KA, Wilson WJ, Macaulay SL, Ryan TM, Martins RN, Ames D, Masters CL, Doecke JD. Bayesian graphical network analyses reveal complex biological interactions specific to Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 917-25. PMID 25613103 DOI: 10.3233/JAD-141497  0.32
2015 Hare DJ, Doecke JD, Faux NG, Rembach A, Volitakis I, Fowler CJ, Grimm R, Doble PA, Cherny RA, Masters CL, Bush AI, Roberts BR. Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation. Acs Chemical Neuroscience. 6: 398-402. PMID 25588002 DOI: 10.1021/cn5003557  0.32
2015 Pietrzak RH, Lim YY, Ames D, Harrington K, Restrepo C, Martins RN, Rembach A, Laws SM, Masters CL, Villemagne VL, Rowe CC, Maruff P. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing. Neurobiology of Aging. 36: 1231-8. PMID 25585532 DOI: 10.1016/j.neurobiolaging.2014.12.015  1
2015 Lim YY, Villemagne VL, Pietrzak RH, Ames D, Ellis KA, Harrington K, Snyder PJ, Martins RN, Masters CL, Rowe CC, Maruff P. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease. Neurobiology of Aging. 36: 1239-44. PMID 25559335 DOI: 10.1016/j.neurobiolaging.2014.12.008  1
2015 Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early progress and future directions. The Lancet. Neurology. 14: 114-24. PMID 25496902 DOI: 10.1016/S1474-4422(14)70252-2  1
2015 Lim YY, Pietrzak RH, Bourgeat P, Ames D, Ellis KA, Rembach A, Harrington K, Salvado O, Martins RN, Snyder PJ, Masters CL, Rowe CC, Villemagne VL, Maruff P. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 30: 49-58. PMID 25467942 DOI: 10.1093/arclin/acu068  0.32
2015 Murphy M, Wilson YM, Vargas E, Munro KM, Smith B, Huang A, Li QX, Xiao J, Masters CL, Reid CA, Barrett GL. Reduction of p75 neurotrophin receptor ameliorates the cognitive deficits in a model of Alzheimer's disease. Neurobiology of Aging. 36: 740-52. PMID 25443284 DOI: 10.1016/j.neurobiolaging.2014.09.014  1
2015 Roberts BR, Hare DJ, McLean CA, Conquest A, Lind M, Li QX, Bush AI, Masters CL, Morganti-Kossmann MC, Frugier T. Traumatic brain injury induces elevation of Co in the human brain. Metallomics : Integrated Biometal Science. 7: 66-70. PMID 25424382 DOI: 10.1039/c4mt00258j  1
2015 Watt AD, Perez KA, Ang CS, O'Donnell P, Rembach A, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Faux NG, Masters CL, Villemagne VL, Barnham KJ. Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 44: 1131-43. PMID 25408207 DOI: 10.3233/JAD-142286  1
2015 Curtain CC, Kirby NM, Mertens HD, Barnham KJ, Knott RB, Masters CL, Cappai R, Rekas A, Kenche VB, Ryan T. Alpha-synuclein oligomers and fibrils originate in two distinct conformer pools: a small angle X-ray scattering and ensemble optimisation modelling study. Molecular Biosystems. 11: 190-6. PMID 25352253 DOI: 10.1039/c4mb00356j  1
2015 Bourgeat P, Villemagne VL, Dore V, Brown B, Macaulay SL, Martins R, Masters CL, Ames D, Ellis K, Rowe CC, Salvado O, Fripp J. Comparison of MR-less PiB SUVR quantification methods. Neurobiology of Aging. 36: S159-66. PMID 25257985 DOI: 10.1016/j.neurobiolaging.2014.04.033  1
2015 Robb E, Perez K, Hung LW, Masters CL, Barnham KJ, Cherny RA, Bush AI, Adlard PA, Finkelstein DI. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer. Journal of Alzheimer's Disease : Jad. 44: 69-78. PMID 25182735 DOI: 10.3233/JAD-132024  1
2015 Hollands S, Lim YY, Buckley R, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Lautenschlager N, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. Journal of Alzheimer's Disease : Jad. 43: 677-86. PMID 25114076 DOI: 10.3233/JAD-140678  1
2015 Gardener SL, Rainey-Smith SR, Barnes MB, Sohrabi HR, Weinborn M, Lim YY, Harrington K, Taddei K, Gu Y, Rembach A, Szoeke C, Ellis KA, Masters CL, Macaulay SL, Rowe CC, et al. Dietary patterns and cognitive decline in an Australian study of ageing. Molecular Psychiatry. 20: 860-6. PMID 25070537 DOI: 10.1038/mp.2014.79  1
2015 Ong KT, Villemagne VL, Bahar-Fuchs A, Lamb F, Langdon N, Catafau AM, Stephens AW, Seibyl J, Dinkelborg LM, Reininger CB, Putz B, Rohde B, Masters CL, Rowe CC. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 431-6. PMID 24970906 DOI: 10.1136/jnnp-2014-308094  0.32
2015 Burnham SC, Raghavan N, Wilson W, Baker D, Ropacki MT, Novak G, Ames D, Ellis K, Martins RN, Maruff P, Masters CL, Romano G, Rowe CC, Savage G, Macaulay SL, et al. Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study Journal of Alzheimer's Disease. 46: 1079-1089. DOI: 10.3233/JAD-143015  1
2015 Grill JD, Bateman RJ, Buckles V, Oliver A, Morris JC, Masters CL, Klunk WE, Ringman JM. A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer's disease Alzheimer's Research and Therapy. 7. DOI: 10.1186/s13195-015-0135-0  1
2015 Li X, Lei P, Tuo Q, Ayton S, Li QX, Moon S, Volitakis I, Liu R, Masters CL, Finkelstein DI, Bush AI. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau Neurotherapeutics. DOI: 10.1007/s13311-015-0378-2  1
2014 Klug GM, Boyd A, Sarros S, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Creutzfeldt-Jakob disease surveillance in Australia, update to December 2013. Communicable Diseases Intelligence Quarterly Report. 38: E348-55. PMID 25631598  0.44
2014 Johnson P, Vandewater L, Wilson W, Maruff P, Savage G, Graham P, Macaulay LS, Ellis KA, Szoeke C, Martins RN, Rowe CC, Masters CL, Ames D, Zhang P. Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease. Bmc Bioinformatics. 15: S11. PMID 25521394 DOI: 10.1186/1471-2105-15-S16-S11  1
2014 Villemagne VL, Masters CL. Alzheimer disease: the landscape of ageing--insights from AD imaging markers. Nature Reviews. Neurology. 10: 678-9. PMID 25366111 DOI: 10.1038/nrneurol.2014.214  1
2014 Zwan MD, Okamura N, Fodero-Tavoletti MT, Furumoto S, Masters CL, Rowe CC, Villemagne VL. Voyage au bout de la nuit: Aβ and tau imaging in dementias. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 58: 398-412. PMID 25358680  1
2014 Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A, Martins RN, Rowe CC, Macaulay SL, Masters CL, Hill AF. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment. Molecular Psychiatry. PMID 25349172 DOI: 10.1038/mp.2014.127  1
2014 Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, Ellis KA, Harrington K, Rembach A, Martins RN, Rowe CC, Masters CL, Maruff P. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease. Molecular Psychiatry. PMID 25288138 DOI: 10.1038/mp.2014.123  1
2014 Caine JM, Churches Q, Waddington L, Nigro J, Breheney K, Masters CL, Nuttall SD, Streltsov VA. Design of non-aggregating variants of Aβ peptide. Biochemical and Biophysical Research Communications. 453: 449-54. PMID 25281534 DOI: 10.1016/j.bbrc.2014.09.102  1
2014 Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC. Genetic heterogeneity in Alzheimer disease and implications for treatment strategies. Current Neurology and Neuroscience Reports. 14: 499. PMID 25217249 DOI: 10.1007/s11910-014-0499-8  1
2014 Brown BM, Bourgeat P, Peiffer JJ, Burnham S, Laws SM, Rainey-Smith SR, Bartrés-Faz D, Villemagne VL, Taddei K, Rembach A, Bush A, Ellis KA, Macaulay SL, Rowe CC, Ames D, ... Masters CL, et al. Influence of BDNF Val66Met on the relationship between physical activity and brain volume. Neurology. 83: 1345-52. PMID 25186863 DOI: 10.1212/WNL.0000000000000867  1
2014 Adlard PA, Li QX, McLean C, Masters CL, Bush AI, Fodero-Tavoletti M, Villemagne V, Barnham KJ. β-amyloid in biological samples: not all Aβ detection methods are created equal. Frontiers in Aging Neuroscience. 6: 203. PMID 25165449 DOI: 10.3389/fnagi.2014.00203  1
2014 Masters CL. Shaken, not sonicated? The New England Journal of Medicine. 371: 571-2. PMID 25099583 DOI: 10.1056/NEJMe1407419  1
2014 Thomas JB, Brier MR, Bateman RJ, Snyder AZ, Benzinger TL, Xiong C, Raichle M, Holtzman DM, Sperling RA, Mayeux R, Ghetti B, Ringman JM, Salloway S, McDade E, Rossor MN, ... ... Masters CL, et al. Functional connectivity in autosomal dominant and late-onset Alzheimer disease. Jama Neurology. 71: 1111-22. PMID 25069482 DOI: 10.1001/jamaneurol.2014.1654  1
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Villemagne VL, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Szoeke C, Masters CL, Rainey-Smith SR, Rembach A, Savage G, et al. Autobiographical narratives relate to Alzheimer's disease biomarkers in older adults. International Psychogeriatrics / Ipa. 26: 1737-46. PMID 24969443 DOI: 10.1017/S1041610214001136  1
2014 Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology. 83: 253-60. PMID 24928124 DOI: 10.1212/WNL.0000000000000596  1
2014 Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, Villemagne VL, Macaulay SL, Bush AI, Martins RN, Ames D, Masters CL, Doecke JD. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. Journal of Neuroimmunology. 273: 65-71. PMID 24907904 DOI: 10.1016/j.jneuroim.2014.05.005  1
2014 Roberts BR, Lim NK, McAllum EJ, Donnelly PS, Hare DJ, Doble PA, Turner BJ, Price KA, Lim SC, Paterson BM, Hickey JL, Rhoads TW, Williams JR, Kanninen KM, Hung LW, ... ... Masters CL, et al. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8021-31. PMID 24899723 DOI: 10.1523/JNEUROSCI.4196-13.2014  1
2014 Okamura N, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Harada R, Yates P, Pejoska S, Kudo Y, Masters CL, Yanai K, Rowe CC, Villemagne VL. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET. Brain : a Journal of Neurology. 137: 1762-71. PMID 24681664 DOI: 10.1093/brain/awu064  1
2014 Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, Cherny RA, McLean C, Grimm R, Martins R, Ames D, Masters CL, Bush AI, Roberts BR. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics : Integrated Biometal Science. 6: 1216-9. PMID 24676028 DOI: 10.1039/c4mt00060a  1
2014 Yates PA, Desmond PM, Phal PM, Steward C, Szoeke C, Salvado O, Ellis KA, Martins RN, Masters CL, Ames D, Villemagne VL, Rowe CC. Incidence of cerebral microbleeds in preclinical Alzheimer disease. Neurology. 82: 1266-73. PMID 24623839 DOI: 10.1212/WNL.0000000000000285  1
2014 Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TL, Ghetti B, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Salloway S, Schofield PR, Sperling RA, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Science Translational Medicine. 6: 226ra30. PMID 24598588 DOI: 10.1126/scitranslmed.3007901  1
2014 Lim YY, Maruff P, Pietrzak RH, Ellis KA, Darby D, Ames D, Harrington K, Martins RN, Masters CL, Szoeke C, Savage G, Villemagne VL, Rowe CC. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 743-751.e1. PMID 24589436 DOI: 10.1016/j.jalz.2013.11.005  1
2014 Fodero-Tavoletti MT, Furumoto S, Taylor L, McLean CA, Mulligan RS, Birchall I, Harada R, Masters CL, Yanai K, Kudo Y, Rowe CC, Okamura N, Villemagne VL. Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies. Alzheimer's Research & Therapy. 6: 11. PMID 24572336 DOI: 10.1186/alzrt240  1
2014 Pietrzak RH, Scott JC, Neumeister A, Lim YY, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC, Maruff P. Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. The British Journal of Psychiatry : the Journal of Mental Science. 204: 400-1. PMID 24526746 DOI: 10.1192/bjp.bp.113.134239  1
2014 Villemagne VL, Furumoto S, Fodero-Tavoletti MT, Mulligan RS, Hodges J, Harada R, Yates P, Piguet O, Pejoska S, Doré V, Yanai K, Masters CL, Kudo Y, Rowe CC, Okamura N. In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 41: 816-26. PMID 24514874 DOI: 10.1007/s00259-013-2681-7  1
2014 Buckley RF, Saling MM, Irish M, Ames D, Rowe CC, Lautenschlager NT, Maruff P, Macaulay SL, Martins RN, Masters CL, Rainey-Smith SR, Rembach A, Savage G, Szoeke C, Ellis KA. Personal memory function in mild cognitive impairment and subjective memory complaints: results from the Australian Imaging, Biomarkers, and Lifestyle (AIBL) Study of Ageing. Journal of Alzheimer's Disease : Jad. 40: 551-61. PMID 24496075 DOI: 10.3233/JAD-131820  1
2014 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington K, Bourgeat P, Bush AI, Martins RN, Masters CL, Rowe CC, Maruff P. Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer's disease: a preliminary study. Plos One. 9: e86498. PMID 24475133 DOI: 10.1371/journal.pone.0086498  1
2014 Johanssen VA, Johanssen T, Masters CL, Hill AF, Barnham KJ, Collins SJ. C-terminal peptides modelling constitutive PrPC processing demonstrate ameliorated toxicity predisposition consequent to α-cleavage. The Biochemical Journal. 459: 103-15. PMID 24438129 DOI: 10.1042/BJ20131378  1
2014 Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Frontiers in Neurology. 4: 205. PMID 24432010 DOI: 10.3389/fneur.2013.00205  1
2014 Zhou L, Salvado O, Dore V, Bourgeat P, Raniga P, Macaulay SL, Ames D, Masters CL, Ellis KA, Villemagne VL, Rowe CC, Fripp J. MR-less surface-based amyloid assessment based on 11C PiB PET. Plos One. 9: e84777. PMID 24427295 DOI: 10.1371/journal.pone.0084777  1
2014 Faux NG, Rembach A, Wiley J, Ellis KA, Ames D, Fowler CJ, Martins RN, Pertile KK, Rumble RL, Trounson B, Masters CL, Bush AI. An anemia of Alzheimer's disease. Molecular Psychiatry. 19: 1227-34. PMID 24419041 DOI: 10.1038/mp.2013.178  1
2014 Coleman BM, Harrison CF, Guo B, Masters CL, Barnham KJ, Lawson VA, Hill AF. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality. Journal of Virology. 88: 2690-703. PMID 24352465 DOI: 10.1128/JVI.02720-13  1
2014 Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, Maruff P, Ames D, Rowe CC, Macaulay SL, Bush AI, Martins RN, Masters CL, Doecke JD. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. Journal of Alzheimer's Disease : Jad. 40: 95-104. PMID 24334723 DOI: 10.3233/JAD-131802  1
2014 Ellis KA, Szoeke C, Bush AI, Darby D, Graham PL, Lautenschlager NT, Macaulay SL, Martins RN, Maruff P, Masters CL, McBride SJ, Pike KE, Rainey-Smith SR, Rembach A, Robertson J, et al. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL). International Psychogeriatrics / Ipa. 26: 543-54. PMID 24252258 DOI: 10.1017/S1041610213001956  1
2014 Moore EM, Ames D, Mander AG, Carne RP, Brodaty H, Woodward MC, Boundy K, Ellis KA, Bush AI, Faux NG, Martins RN, Masters CL, Rowe CC, Szoeke C, Watters DA. Among vitamin B12 deficient older people, high folate levels are associated with worse cognitive function: combined data from three cohorts. Journal of Alzheimer's Disease : Jad. 39: 661-8. PMID 24246419 DOI: 10.3233/JAD-131265  1
2014 Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease. Brain : a Journal of Neurology. 137: 221-31. PMID 24176981 DOI: 10.1093/brain/awt286  1
2014 Pham CL, Kirby N, Wood K, Ryan T, Roberts B, Sokolova A, Barnham KJ, Masters CL, Knott RB, Cappai R, Curtain CC, Rekas A. Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: a small-angle X-ray scattering study. Proteins. 82: 10-21. PMID 23733394 DOI: 10.1002/prot.24332  1
2014 Burnham SC, Faux NG, Wilson W, Laws SM, Ames D, Bedo J, Bush AI, Doecke JD, Ellis KA, Head R, Jones G, Kiiveri H, Martins RN, Rembach A, Rowe CC, ... ... Masters CL, et al. A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study. Molecular Psychiatry. 19: 519-26. PMID 23628985 DOI: 10.1038/mp.2013.40  1
2014 Rembach A, Faux NG, Watt AD, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Roberts BR, Perez KA, Li QX, Laws SM, Taddei K, Rainey-Smith S, Robertson JS, Vandijck M, ... ... Masters CL, et al. Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 53-61. PMID 23491263 DOI: 10.1016/j.jalz.2012.12.006  1
2014 Verdile G, Laws SM, Henley D, Ames D, Bush AI, Ellis KA, Faux NG, Gupta VB, Li QX, Masters CL, Pike KE, Rowe CC, Szoeke C, Taddei K, Villemagne VL, et al. Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer's disease. Molecular Psychiatry. 19: 69-75. PMID 23089633 DOI: 10.1038/mp.2012.147  1
2014 Drew SC, Masters CL, Barnham KJ. Alzheimer's Aβ peptides with disease-associated N-terminal modifications: Influence of isomerisation, truncation and mutation on Cu 2+ coordination (PLoS ONE (2010) 5, 12 (e15875) DOI: 10.1371/journal.pone.0015875) Plos One. 9. DOI: 10.1371/journal.pone.0102192  1
2014 Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. Errratum: The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue (Journal of Analytical Atomic Spectrometry (2013) DOI: 10.1039/C3JA50281C) Journal of Analytical Atomic Spectrometry. 29: 1726. DOI: 10.1039/C4JA90043J  1
2014 Hare DJ, Lei P, Ayton S, Roberts BR, Grimm R, George JL, Bishop DP, Beavis AD, Donovan SJ, McColl G, Volitakis I, Masters CL, Adlard PA, Cherny RA, Bush AI, et al. An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta Chemical Science. 5: 2160-2169. DOI: 10.1039/c3sc53461h  1
2014 Hare DJ, George JL, Bray L, Volitakis I, Vais A, Ryan TM, Cherny RA, Bush AI, Masters CL, Adlard PA, Doble PA, Finkelstein DI. The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue Journal of Analytical Atomic Spectrometry. 29: 565-570. DOI: 10.1039/c3ja50281c  1
2014 Villemagne VL, Fodero-Tavoletti M, Yates P, Masters CL, Rowe CC. Aâ imaging in aging, alzheimer’s disease and other neurodegenerative conditions Pet and Spect in Neurology. 213-254. DOI: 10.1007/978-3-642-54307-4_10  1
2013 Maruff P, Lim YY, Darby D, Ellis KA, Pietrzak RH, Snyder PJ, Bush AI, Szoeke C, Schembri A, Ames D, Masters CL. Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease. Bmc Psychology. 1: 30. PMID 25566378 DOI: 10.1186/2050-7283-1-30  0.52
2013 Rowe CC, Bourgeat P, Ellis KA, Brown B, Lim YY, Mulligan R, Jones G, Maruff P, Woodward M, Price R, Robins P, Tochon-Danguy H, O'Keefe G, Pike KE, Yates P, ... ... Masters CL, et al. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Annals of Neurology. 74: 905-13. PMID 24448836 DOI: 10.1002/ana.24040  1
2013 Szoeke CE, Robertson JS, Rowe CC, Yates P, Campbell K, Masters CL, Ames D, Dennerstein L, Desmond P. The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementia. International Review of Psychiatry (Abingdon, England). 25: 726-37. PMID 24423225 DOI: 10.3109/09540261.2013.873394  1
2013 Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, Bush AI, Masters CL, Roberts BR. Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction. International Journal of Alzheimer's Disease. 2013: 623241. PMID 24228186 DOI: 10.1155/2013/623241  1
2013 Benzinger TL, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, ... ... Masters CL, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: E4502-9. PMID 24194552 DOI: 10.1073/pnas.1317918110  1
2013 Klug GM, Boyd A, Zhao T, Stehmann C, Simpson M, McLean CA, Masters CL, Collins SJ. Surveillance for Creutzfeldt-Jakob disease in Australia: update to December 2012. Communicable Diseases Intelligence Quarterly Report. 37: E115-20. PMID 24168084  1
2013 Hare DJ, Grubman A, Ryan TM, Lothian A, Liddell JR, Grimm R, Matsuda T, Doble PA, Cherny RA, Bush AI, White AR, Masters CL, Roberts BR. Profiling the iron, copper and zinc content in primary neuron and astrocyte cultures by rapid online quantitative size exclusion chromatography-inductively coupled plasma-mass spectrometry. Metallomics : Integrated Biometal Science. 5: 1656-62. PMID 24132241 DOI: 10.1039/c3mt00227f  1
2013 Frost S, Kanagasingam Y, Sohrabi H, Bourgeat P, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN. Pupil response biomarkers for early detection and monitoring of Alzheimer's disease. Current Alzheimer Research. 10: 931-9. PMID 24117119  1
2013 Cash DM, Ridgway GR, Liang Y, Ryan NS, Kinnunen KM, Yeatman T, Malone IB, Benzinger TL, Jack CR, Thompson PM, Ghetti BF, Saykin AJ, Masters CL, Ringman JM, Salloway SP, et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology. 81: 1425-33. PMID 24049139 DOI: 10.1212/WNL.0b013e3182a841c6  1
2013 Klug GM, Wand H, Simpson M, Boyd A, Law M, Masters CL, MatÄ›j R, Howley R, Farrell M, Breithaupt M, Zerr I, van Duijn C, Ibrahim-Verbaas C, Mackenzie J, Will RG, et al. Intensity of human prion disease surveillance predicts observed disease incidence. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1372-7. PMID 23965290 DOI: 10.1136/jnnp-2012-304820  1
2013 Frost SM, Kanagasingam Y, Sohrabi HR, Taddei K, Bateman R, Morris J, Benzinger T, Goate A, Masters CL, Martins RN. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Current Alzheimer Research. 10: 790-6. PMID 23919771 DOI: 10.2174/15672050113109990154  1
2013 Rembach A, Ryan TM, Roberts BR, Doecke JD, Wilson WJ, Watt AD, Barnham KJ, Masters CL. Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. Biomarkers in Medicine. 7: 641-62. PMID 23905901 DOI: 10.2217/bmm.13.59  1
2013 Lothian A, Hare DJ, Grimm R, Ryan TM, Masters CL, Roberts BR. Metalloproteomics: principles, challenges and applications to neurodegeneration. Frontiers in Aging Neuroscience. 5: 35. PMID 23882215 DOI: 10.3389/fnagi.2013.00035  1
2013 Harrington KD, Lim YY, Ellis KA, Copolov C, Darby D, Weinborn M, Ames D, Martins RN, Savage G, Szoeke C, Rowe C, Villemagne VL, Masters CL, Maruff P. The association of Aβ amyloid and composite cognitive measures in healthy older adults and MCI. International Psychogeriatrics / Ipa. 25: 1667-77. PMID 23866942 DOI: 10.1017/S1041610213001087  1
2013 Simpson M, Johanssen V, Boyd A, Klug G, Masters CL, Li QX, Pamphlett R, McLean C, Lewis V, Collins SJ. Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G). Jama Neurology. 70: 1180-5. PMID 23857164 DOI: 10.1001/jamaneurol.2013.165  1
2013 Lim YY, Villemagne VL, Laws SM, Ames D, Pietrzak RH, Ellis KA, Harrington KD, Bourgeat P, Salvado O, Darby D, Snyder PJ, Bush AI, Martins RN, Masters CL, Rowe CC, et al. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease. Neurobiology of Aging. 34: 2457-64. PMID 23769397 DOI: 10.1016/j.neurobiolaging.2013.05.006  1
2013 Foster JK, Albrecht MA, Savage G, Lautenschlager NT, Ellis KA, Maruff P, Szoeke C, Taddei K, Martins R, Masters CL, Ames D. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain : a Journal of Neurology. 136: 2201-16. PMID 23737466 DOI: 10.1093/brain/awt127  1
2013 Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. Jama Neurology. 70: 903-11. PMID 23712469 DOI: 10.1001/jamaneurol.2013.1062  1
2013 Buckley R, Saling MM, Ames D, Rowe CC, Lautenschlager NT, Macaulay SL, Martins RN, Masters CL, O'Meara T, Savage G, Szoeke C, Villemagne VL, Ellis KA. Factors affecting subjective memory complaints in the AIBL aging study: biomarkers, memory, affect, and age. International Psychogeriatrics / Ipa. 25: 1307-15. PMID 23693133 DOI: 10.1017/S1041610213000665  1
2013 Lim YY, Ellis KA, Harrington K, Kamer A, Pietrzak RH, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Ames D, Maruff P. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease. Neuropsychology. 27: 322-32. PMID 23688214 DOI: 10.1037/a0032321  1
2013 Ryan TM, Caine J, Mertens HD, Kirby N, Nigro J, Breheney K, Waddington LJ, Streltsov VA, Curtain C, Masters CL, Roberts BR. Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization. Peerj. 1: e73. PMID 23678397 DOI: 10.7717/peerj.73  1
2013 Nisbet RM, Nuttall SD, Robert R, Caine JM, Dolezal O, Hattarki M, Pearce LA, Davydova N, Masters CL, Varghese JN, Streltsov VA. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide. Proteins. 81: 1748-58. PMID 23609990 DOI: 10.1002/prot.24312  1
2013 Rowe CC, Pejoska S, Mulligan RS, Jones G, Chan JG, Svensson S, Cselényi Z, Masters CL, Villemagne VL. Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 880-6. PMID 23575995 DOI: 10.2967/jnumed.112.114785  1
2013 Lim YY, Jaeger J, Harrington K, Ashwood T, Ellis KA, Stöffler A, Szoeke C, Lachovitzki R, Martins RN, Villemagne VL, Bush A, Masters CL, Rowe CC, Ames D, Darby D, et al. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS). Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 28: 320-30. PMID 23552802 DOI: 10.1093/arclin/act021  1
2013 Kenche VB, Zawisza I, Masters CL, Bal W, Barnham KJ, Drew SC. Mixed ligand Cu2+ complexes of a model therapeutic with Alzheimer's amyloid-β peptide and monoamine neurotransmitters. Inorganic Chemistry. 52: 4303-18. PMID 23537393 DOI: 10.1021/ic302289r  1
2013 Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. The Lancet. Neurology. 12: 357-67. PMID 23477989 DOI: 10.1016/S1474-4422(13)70044-9  1
2013 Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, Villemagne V, Rowe CC, Macaulay SL, Szoeke C, Ellis KA, Ames D, Masters CL, Rainey-Smith S, Martins RN, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Translational Psychiatry. 3: e233. PMID 23443359 DOI: 10.1038/tp.2012.150  1
2013 Kenche VB, Hung LW, Perez K, Volitakes I, Ciccotosto G, Kwok J, Critch N, Sherratt N, Cortes M, Lal V, Masters CL, Murakami K, Cappai R, Adlard PA, Barnham KJ. Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease. Angewandte Chemie (International Ed. in English). 52: 3374-8. PMID 23401085 DOI: 10.1002/anie.201209885  1
2013 Watt AD, Perez KA, Rembach A, Sherrat NA, Hung LW, Johanssen T, McLean CA, Kok WM, Hutton CA, Fodero-Tavoletti M, Masters CL, Villemagne VL, Barnham KJ. Oligomers, fact or artefact? SDS-PAGE induces dimerization of β-amyloid in human brain samples. Acta Neuropathologica. 125: 549-64. PMID 23354835 DOI: 10.1007/s00401-013-1083-z  1
2013 Ong K, Villemagne VL, Bahar-Fuchs A, Lamb F, Chételat G, Raniga P, Mulligan RS, Salvado O, Putz B, Roth K, Masters CL, Reininger CB, Rowe CC. (18)F-florbetaben Aβ imaging in mild cognitive impairment. Alzheimer's Research & Therapy. 5: 4. PMID 23324163 DOI: 10.1186/alzrt158  1
2013 Ellis KA, Lim YY, Harrington K, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 34: 861-71. PMID 23302660 DOI: 10.3233/JAD-122170  1
2013 Carrillo MC, Rowe CC, Szoeke C, Masters CL, Ames D, O'Meara T, Macaulay SL, Milner A, Ellis KA, Maruff P, Rainey-Smith SR, Martins RN, Bain LJ, Head RJ. Research and standardization in Alzheimer's trials: reaching international consensus. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 160-8. PMID 23266004 DOI: 10.1016/j.jalz.2012.10.006  1
2013 Rembach A, Doecke JD, Roberts BR, Watt AD, Faux NG, Volitakis I, Pertile KK, Rumble RL, Trounson BO, Fowler CJ, Wilson W, Ellis KA, Martins RN, Rowe CC, Villemagne VL, ... ... Masters CL, et al. Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 34: 171-82. PMID 23168449 DOI: 10.3233/JAD-121474  1
2013 Lim YY, Ellis KA, Harrington K, Pietrzak RH, Gale J, Ames D, Bush AI, Darby D, Martins RN, Masters CL, Rowe CC, Savage G, Szoeke C, Villemagne VL, Maruff P. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease? Journal of Alzheimer's Disease : Jad. 33: 1167-76. PMID 23160011 DOI: 10.3233/JAD-121771  1
2013 Lim YY, Ellis KA, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Aβ amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 538-45. PMID 23159043 DOI: 10.1016/j.jalz.2012.07.004  1
2013 Lim YY, Pietrzak RH, Ellis KA, Jaeger J, Harrington K, Ashwood T, Szoeke C, Martins RN, Bush AI, Masters CL, Rowe CC, Villemagne VL, Ames D, Darby D, Maruff P. Rapid decline in episodic memory in healthy older adults with high amyloid-β. Journal of Alzheimer's Disease : Jad. 33: 675-9. PMID 23001710 DOI: 10.3233/JAD-2012-121516  1
2013 Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, et al. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing. Molecular Psychiatry. 18: 875-81. PMID 22889922 DOI: 10.1038/mp.2012.107  1
2013 Ryan TM, Roberts BR, Streltsov VA, Nuttall SD, Masters CL. The Role of Aβ in Alzheimer's Disease Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties. 263-293. DOI: 10.1002/9783527654185.ch13  1
2012 Klug GM, Boyd A, McGlade A, Stehmann C, Simpson M, Masters CL, Collins SJ. Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2011. Communicable Diseases Intelligence Quarterly Report. 36: E174-9. PMID 23186216  1
2012 McColl G, Roberts BR, Pukala TL, Kenche VB, Roberts CM, Link CD, Ryan TM, Masters CL, Barnham KJ, Bush AI, Cherny RA. Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Molecular Neurodegeneration. 7: 57. PMID 23171715 DOI: 10.1186/1750-1326-7-57  1
2012 Brown BM, Peiffer JJ, Sohrabi HR, Mondal A, Gupta VB, Rainey-Smith SR, Taddei K, Burnham S, Ellis KA, Szoeke C, Masters CL, Ames D, Rowe CC, Martins RN. Intense physical activity is associated with cognitive performance in the elderly. Translational Psychiatry. 2: e191. PMID 23168991 DOI: 10.1038/tp.2012.118  1
2012 Morris JC, Aisen PS, Bateman RJ, Benzinger TL, Cairns NJ, Fagan AM, Ghetti B, Goate AM, Holtzman DM, Klunk WE, McDade E, Marcus DS, Martins RN, Masters CL, Mayeux R, et al. Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clinical Investigation. 2: 975-984. PMID 23139856 DOI: 10.4155/cli.12.93  0.36
2012 Lim YY, Ellis KA, Pietrzak RH, Ames D, Darby D, Harrington K, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Villemagne VL, Maruff P. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology. 79: 1645-52. PMID 23071163 DOI: 10.1212/WNL.0b013e31826e9ae6  1
2012 Cyarto EV, Lautenschlager NT, Desmond PM, Ames D, Szoeke C, Salvado O, Sharman MJ, Ellis KA, Phal PM, Masters CL, Rowe CC, Martins RN, Cox KL. Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. Bmc Psychiatry. 12: 167. PMID 23050829 DOI: 10.1186/1471-244X-12-167  1
2012 Gardener S, Gu Y, Rainey-Smith SR, Keogh JB, Clifton PM, Mathieson SL, Taddei K, Mondal A, Ward VK, Scarmeas N, Barnes M, Ellis KA, Head R, Masters CL, Ames D, et al. Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian population. Translational Psychiatry. 2: e164. PMID 23032941 DOI: 10.1038/tp.2012.91  1
2012 Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, ... ... Masters CL, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/j.jalz.2012.08.001  1
2012 Klemm HM, Welton JM, Masters CL, Klug GM, Boyd A, Hill AF, Collins SJ, Lawson VA. The prion protein preference of sporadic Creutzfeldt-Jakob disease subtypes. The Journal of Biological Chemistry. 287: 36465-72. PMID 22930754 DOI: 10.1074/jbc.M112.368803  1
2012 Doecke JD, Laws SM, Faux NG, Wilson W, Burnham SC, Lam CP, Mondal A, Bedo J, Bush AI, Brown B, De Ruyck K, Ellis KA, Fowler C, Gupta VB, Head R, ... ... Masters CL, et al. Blood-based protein biomarkers for diagnosis of Alzheimer disease. Archives of Neurology. 69: 1318-25. PMID 22801742 DOI: 10.1001/archneurol.2012.1282  1
2012 Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, ... ... Masters CL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. The New England Journal of Medicine. 367: 795-804. PMID 22784036 DOI: 10.1056/NEJMoa1202753  1
2012 Anand A, Banik A, Thakur K, Masters CL. The animal models of dementia and Alzheimer's disease for pre-clinical testing and clinical translation. Current Alzheimer Research. 9: 1010-29. PMID 22698073 DOI: 10.2174/156720512803569055  1
2012 Masters CL, Selkoe DJ. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine. 2: a006262. PMID 22675658 DOI: 10.1101/cshperspect.a006262  1
2012 Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain : a Journal of Neurology. 135: 2126-39. PMID 22628162 DOI: 10.1093/brain/aws125  1
2012 Lewis V, Haigh CL, Masters CL, Hill AF, Lawson VA, Collins SJ. Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity. Molecular Neurodegeneration. 7: 18. PMID 22534096 DOI: 10.1186/1750-1326-7-18  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. sAPPα rescues deficits in amyloid precursor protein knockout mice following focal traumatic brain injury. Journal of Neurochemistry. 122: 208-20. PMID 22519988 DOI: 10.1111/j.1471-4159.2012.07761.x  1
2012 Fodero-Tavoletti MT, Brockschnieder D, Villemagne VL, Martin L, Connor AR, Thiele A, Berndt M, McLean CA, Krause S, Rowe CC, Masters CL, Dinkelborg L, Dyrks T, Cappai R. In vitro characterization of [18F]-florbetaben, an Aβ imaging radiotracer. Nuclear Medicine and Biology. 39: 1042-8. PMID 22503458 DOI: 10.1016/j.nucmedbio.2012.03.001  1
2012 Hung LW, Villemagne VL, Cheng L, Sherratt NA, Ayton S, White AR, Crouch PJ, Lim S, Leong SL, Wilkins S, George J, Roberts BR, Pham CL, Liu X, Chiu FC, ... ... Masters CL, et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease. The Journal of Experimental Medicine. 209: 837-54. PMID 22473957 DOI: 10.1084/jem.20112285  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Evaluation of the effects of treatment with sAPPα on functional and histological outcome following controlled cortical impact injury in mice. Neuroscience Letters. 515: 50-4. PMID 22445885 DOI: 10.1016/j.neulet.2012.03.017  1
2012 Watt AD, Perez KA, Rembach AR, Masters CL, Villemagne VL, Barnham KJ. Variability in blood-based amyloid-beta assays: the need for consensus on pre-analytical processing. Journal of Alzheimer's Disease : Jad. 30: 323-36. PMID 22426018 DOI: 10.3233/JAD-2012-120058  1
2012 Corrigan F, Vink R, Blumbergs PC, Masters CL, Cappai R, van den Heuvel C. Characterisation of the effect of knockout of the amyloid precursor protein on outcome following mild traumatic brain injury. Brain Research. 1451: 87-99. PMID 22424792 DOI: 10.1016/j.brainres.2012.02.045  1
2012 Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O'Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 983-9. PMID 22398958 DOI: 10.1007/s00259-012-2088-x  1
2012 Chételat G, Villemagne VL, Villain N, Jones G, Ellis KA, Ames D, Martins RN, Masters CL, Rowe CC. Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition. Neurology. 78: 477-84. PMID 22302548 DOI: 10.1212/WNL.0b013e318246d67a  1
2012 Chételat G, Villemagne VL, Pike KE, Ellis KA, Ames D, Masters CL, Rowe CC. Relationship between memory performance and β-amyloid deposition at different stages of Alzheimer's disease. Neuro-Degenerative Diseases. 10: 141-4. PMID 22301812 DOI: 10.1159/000334295  1
2012 Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, O'Keefe G, Jones G, Kung HF, Pontecorvo M, Masters CL, Skovronsky DM, Rowe CC. Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imaging. Neuro-Degenerative Diseases. 10: 161-5. PMID 22261520 DOI: 10.1159/000334535  1
2012 Lim YY, Ellis KA, Harrington K, Ames D, Martins RN, Masters CL, Rowe C, Savage G, Szoeke C, Darby D, Maruff P, The Aibl Research Group. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study. Journal of Clinical and Experimental Neuropsychology. 34: 345-58. PMID 22248010 DOI: 10.1080/13803395.2011.643227  1
2012 Acosta O, Fripp J, Doré V, Bourgeat P, Favreau JM, Chételat G, Rueda A, Villemagne VL, Szoeke C, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Bonner E, et al. Cortical surface mapping using topology correction, partial flattening and 3D shape context-based non-rigid registration for use in quantifying atrophy in Alzheimer's disease. Journal of Neuroscience Methods. 205: 96-109. PMID 22226742 DOI: 10.1016/j.jneumeth.2011.12.011  1
2012 Villemagne VL, Klunk WE, Mathis CA, Rowe CC, Brooks DJ, Hyman BT, Ikonomovic MD, Ishii K, Jack CR, Jagust WJ, Johnson KA, Koeppe RA, Lowe VJ, Masters CL, Montine TJ, et al. Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. 39: 209-19. PMID 22218879 DOI: 10.1007/s00259-011-2045-0  1
2012 Johanssen VA, Barnham KJ, Masters CL, Hill AF, Collins SJ. Generating recombinant C-terminal prion protein fragments of exact native sequence. Neurochemistry International. 60: 318-26. PMID 22197912 DOI: 10.1016/j.neuint.2011.12.006  1
2012 Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. The role of metallobiology and amyloid-β peptides in Alzheimer's disease. Journal of Neurochemistry. 120: 149-66. PMID 22121980 DOI: 10.1111/j.1471-4159.2011.07500.x  1
2012 James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, Bush AI. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radical Biology & Medicine. 52: 298-302. PMID 22080049 DOI: 10.1016/j.freeradbiomed.2011.10.446  1
2012 Sona A, Zhang P, Ames D, Bush AI, Lautenschlager NT, Martins RN, Masters CL, Rowe CC, Szoeke C, Taddei K, Ellis KA. Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing. International Psychogeriatrics / Ipa. 24: 197-204. PMID 21749739 DOI: 10.1017/S1041610211001335  1
2012 Villemagne VL, Furumoto S, Fodero-Tavoletti M, Harada R, Mulligan RS, Kudo Y, Masters CL, Yanai K, Rowe CC, Okamura N. The challenges of tau imaging Future Neurology. 7: 409-421. DOI: 10.2217/fnl.12.34  1
2012 Doré V, Bourgeat P, Fripp J, Acosta O, Chetelat G, Szoeke C, Ellis KA, Martins RN, Villemagne V, Masters CL, Ames D, Rowe CC, Salvado O. A surface based approach for cortical thickness comparison between PiB+ and PiB-healthy control subjects Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911752  1
2011 Soon CP, Donnelly PS, Turner BJ, Hung LW, Crouch PJ, Sherratt NA, Tan JL, Lim NK, Lam L, Bica L, Lim S, Hickey JL, Morizzi J, Powell A, Finkelstein DI, ... ... Masters CL, et al. Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. The Journal of Biological Chemistry. 286: 44035-44. PMID 22033929 DOI: 10.1074/jbc.M111.274407  1
2011 Klug GM, Boyd A, McGlade A, Stehmann C, Masters CL, Collins SJ. Surveillance of Creutzfeldt-Jakob disease in Australia: update to December 2010. Communicable Diseases Intelligence Quarterly Report. 35: 149-53. PMID 22010507  1
2011 Lawson VA, Klemm HM, Welton JM, Masters CL, Crouch P, Cappai R, Ciccotosto GD. Gene knockout of tau expression does not contribute to the pathogenesis of prion disease. Journal of Neuropathology and Experimental Neurology. 70: 1036-45. PMID 22002429 DOI: 10.1097/NEN.0b013e318235b471  1
2011 Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, Szoeke C, Taddei K, Taddei T, Trounson BO, Villemagne VL, ... ... Masters CL, et al. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study. Journal of Alzheimer's Disease : Jad. 27: 909-22. PMID 21891867 DOI: 10.3233/JAD-2011-110752  1
2011 Meyerowitz J, Parker SJ, Vella LJ, Ng DCh, Price KA, Liddell JR, Caragounis A, Li QX, Masters CL, Nonaka T, Hasegawa M, Bogoyevitch MA, Kanninen KM, Crouch PJ, White AR. C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Molecular Neurodegeneration. 6: 57. PMID 21819629 DOI: 10.1186/1750-1326-6-57  1
2011 Crouch PJ, Savva MS, Hung LW, Donnelly PS, Mot AI, Parker SJ, Greenough MA, Volitakis I, Adlard PA, Cherny RA, Masters CL, Bush AI, Barnham KJ, White AR. The Alzheimer's therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity. Journal of Neurochemistry. 119: 220-30. PMID 21797865 DOI: 10.1111/j.1471-4159.2011.07402.x  1
2011 Villemagne VL, Ong K, Mulligan RS, Holl G, Pejoska S, Jones G, O'Keefe G, Ackerman U, Tochon-Danguy H, Chan JG, Reininger CB, Fels L, Putz B, Rohde B, Masters CL, et al. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1210-7. PMID 21764791 DOI: 10.2967/jnumed.111.089730  1
2011 Villemagne VL, Okamura N, Pejoska S, Drago J, Mulligan RS, Chételat G, Ackermann U, O'Keefe G, Jones G, Gong S, Tochon-Danguy H, Kung HF, Masters CL, Skovronsky DM, Rowe CC. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease. Archives of Neurology. 68: 905-12. PMID 21747030 DOI: 10.1001/archneurol.2011.142  1
2011 Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology. 77: 48-54. PMID 21700585 DOI: 10.1212/WNL.0b013e318221ad36  1
2011 Lim NK, Villemagne VL, Soon CP, Laughton KM, Rowe CC, McLean CA, Masters CL, Evin G, Li QX. Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 26: 779-86. PMID 21694463 DOI: 10.3233/JAD-2011-101974  1
2011 Fodero-Tavoletti MT, Villemagne VL, Rowe CC, Masters CL, Barnham KJ, Cappai R. Amyloid-β: the seeds of darkness. The International Journal of Biochemistry & Cell Biology. 43: 1247-51. PMID 21601003 DOI: 10.1016/j.biocel.2011.05.001  1
2011 Pike KE, Ellis KA, Villemagne VL, Good N, Chételat G, Ames D, Szoeke C, Laws SM, Verdile G, Martins RN, Masters CL, Rowe CC. Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL study. Neuropsychologia. 49: 2384-90. PMID 21529702 DOI: 10.1016/j.neuropsychologia.2011.04.012  1
2011 Lambert JC, Dallongeville J, Ellis KA, Schraen-Maschke S, Lui J, Laws S, Dumont J, Richard F, Cottel D, Berr C, Ames D, Masters CL, Rowe CC, Szoeke C, Tzourio C, et al. Association of plasma Aß peptides with blood pressure in the elderly. Plos One. 6: e18536. PMID 21525986 DOI: 10.1371/journal.pone.0018536  1
2011 Haigh CL, McGlade AR, Lewis V, Masters CL, Lawson VA, Collins SJ. Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro. Free Radical Biology & Medicine. 51: 594-608. PMID 21466851 DOI: 10.1016/j.freeradbiomed.2011.03.035  1
2011 Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, Hill AF, Masters CL, McLean C, Evin G. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiology of Disease. 43: 176-83. PMID 21440067 DOI: 10.1016/j.nbd.2011.03.009  1
2011 Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, Cao D, Rigopoulos A, Cartwright GA, O'Keefe G, Gong S, Adlard PA, Barnham KJ, Rowe CC, Masters CL, et al. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain : a Journal of Neurology. 134: 1089-100. PMID 21436112 DOI: 10.1093/brain/awr038  1
2011 Ellis KA, Rowe CC, Szoeke CE, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat PT, Salvado O. Advances in structural and molecular neuroimaging in Alzheimer's disease. The Medical Journal of Australia. 194: S20-3. PMID 21401483  1
2011 McBride SJ, Szoeke CE, Good NM, Ames D, Martins RN, Masters CL, Maruff PT, Rowe CC, Savage G, Ellis KA. A web-based normative data tool for assessing cognitive performance in healthy older Australians. The Medical Journal of Australia. 194: S12-4. PMID 21401481  1
2011 Sittironnarit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Hilmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe C, Szoeke C, Ellis KA. Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study. Dementia and Geriatric Cognitive Disorders. 31: 173-8. PMID 21389718 DOI: 10.1159/000325171  1
2011 Drew SC, Haigh CL, Klemm HM, Masters CL, Collins SJ, Barnham KJ, Lawson VA. Optical imaging detects apoptosis in the brain and peripheral organs of prion-infected mice. Journal of Neuropathology and Experimental Neurology. 70: 143-50. PMID 21343883 DOI: 10.1097/NEN.0b013e3182084a8c  1
2011 Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease. Brain : a Journal of Neurology. 134: 798-807. PMID 21310725 DOI: 10.1093/brain/awq383  1
2011 Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, ... Masters CL, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Annals of Neurology. 69: 181-92. PMID 21280088 DOI: 10.1002/ana.22248  1
2011 Streltsov VA, Varghese JN, Masters CL, Nuttall SD. Crystal structure of the amyloid-β p3 fragment provides a model for oligomer formation in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 1419-26. PMID 21273426 DOI: 10.1523/JNEUROSCI.4259-10.2011  1
2011 Masters CL, Kril JJ, Halliday GM, Pamphlett R, Collins S, Hill AF, McLean C. Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology. 43: 93-102. PMID 21233670 DOI: 10.1097/PAT.0b013e3283426eee  1
2011 Corrigan F, Pham CL, Vink R, Blumbergs PC, Masters CL, van den Heuvel C, Cappai R. The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains. Brain Research. 1378: 137-43. PMID 21215734 DOI: 10.1016/j.brainres.2010.12.077  1
2011 Acevedo KM, Hung YH, Dalziel AH, Li QX, Laughton K, Wikhe K, Rembach A, Roberts B, Masters CL, Bush AI, Camakaris J. Copper promotes the trafficking of the amyloid precursor protein. The Journal of Biological Chemistry. 286: 8252-62. PMID 21177866 DOI: 10.1074/jbc.M110.128512  1
2011 Watt AD, Perez KA, Faux NG, Pike KE, Rowe CC, Bourgeat P, Salvado O, Masters CL, Villemagne VL, Barnham KJ. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 24: 47-59. PMID 21157020 DOI: 10.3233/JAD-2010-101722  1
2011 Ciccotosto GD, Tew DJ, Drew SC, Smith DG, Johanssen T, Lal V, Lau TL, Perez K, Curtain CC, Wade JD, Separovic F, Masters CL, Smith JP, Barnham KJ, Cappai R. Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity. Neurobiology of Aging. 32: 235-48. PMID 19324459 DOI: 10.1016/j.neurobiolaging.2009.02.018  1
2011 Masters CL, Beyreuther K. Amyloid-β Production Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders: Second Edition. 92-96. DOI: 10.1002/9781444341256.ch11  1
2011 Boyd A, Klug GMJA, Masters CL, Collins SJ. In reply Medical Journal of Australia. 194: 215.  1
2010 Lawson VA, Haigh CL, Roberts B, Kenche VB, Klemm HM, Masters CL, Collins SJ, Barnham KJ, Drew SC. Near-infrared fluorescence imaging of apoptotic neuronal cell death in a live animal model of prion disease. Acs Chemical Neuroscience. 1: 720-7. PMID 22778809 DOI: 10.1021/cn100068x  1
2010 Drew SC, Masters CL, Barnham KJ. Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination. Plos One. 5: e15875. PMID 21209855 DOI: 10.1371/journal.pone.0015875  1
2010 Collins SJ, McGlade A, Boyd A, Masters CL, Klug GM. 14-3-3 protein detection and sporadic CJD: the status quo serves well while awaiting progress. Journal of Neurology, Neurosurgery, and Psychiatry. 81: 1181. PMID 20972202 DOI: 10.1136/jnnp.2010.219691  1
2010 Bahar-Fuchs A, Chételat G, Villemagne VL, Moss S, Pike K, Masters CL, Rowe C, Savage G. Olfactory deficits and amyloid-β burden in Alzheimer's disease, mild cognitive impairment, and healthy aging: a PiB PET study. Journal of Alzheimer's Disease : Jad. 22: 1081-7. PMID 20930316 DOI: 10.3233/JAD-2010-100696  1
2010 Boyd A, Klug GM, Schonberger LB, McGlade A, Brandel JP, Masters CL, Collins SJ. Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? The Medical Journal of Australia. 193: 366-9. PMID 20854243  1
2010 Gunn AP, Masters CL, Cherny RA. Pyroglutamate-Aβ: role in the natural history of Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. 42: 1915-8. PMID 20833262 DOI: 10.1016/j.biocel.2010.08.015  1
2010 Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, Leong SL, Perez K, Johanssen T, Greenough MA, Cho HH, Galatis D, Moir RD, Masters CL, McLean C, et al. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell. 142: 857-67. PMID 20817278 DOI: 10.1016/j.cell.2010.08.014  1
2010 Evin G, Barakat A, Masters CL. BACE: Therapeutic target and potential biomarker for Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. 42: 1923-6. PMID 20817005 DOI: 10.1016/j.biocel.2010.08.017  1
2010 Lawson VA, Lumicisi B, Welton J, Machalek D, Gouramanis K, Klemm HM, Stewart JD, Masters CL, Hoke DE, Collins SJ, Hill AF. Glycosaminoglycan sulphation affects the seeded misfolding of a mutant prion protein. Plos One. 5: e12351. PMID 20808809 DOI: 10.1371/journal.pone.0012351  1
2010 Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC. Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain : a Journal of Neurology. 133: 3349-58. PMID 20739349 DOI: 10.1093/brain/awq187  1
2010 Boland MP, Hatty CR, Separovic F, Hill AF, Tew DJ, Barnham KJ, Haigh CL, James M, Masters CL, Collins SJ. Anionic phospholipid interactions of the prion protein N terminus are minimally perturbing and not driven solely by the octapeptide repeat domain. The Journal of Biological Chemistry. 285: 32282-92. PMID 20679345 DOI: 10.1074/jbc.M110.123398  1
2010 Lei P, Ayton S, Finkelstein DI, Adlard PA, Masters CL, Bush AI. Tau protein: relevance to Parkinson's disease. The International Journal of Biochemistry & Cell Biology. 42: 1775-8. PMID 20678581 DOI: 10.1016/j.biocel.2010.07.016  1
2010 Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, ... ... Masters CL, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging. 31: 1275-83. PMID 20472326 DOI: 10.1016/j.neurobiolaging.2010.04.007  1
2010 George S, Mok SS, Nurjono M, Ayton S, Finkelstein DI, Masters CL, Li QX, Culvenor JG. α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment. Journal of Molecular Neuroscience : Mn. 42: 243-54. PMID 20464527 DOI: 10.1007/s12031-010-9378-1  1
2010 Brazier MW, Volitakis I, Kvasnicka M, White AR, Underwood JR, Green JE, Han S, Hill AF, Masters CL, Collins SJ. Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. Journal of Neurochemistry. 114: 440-51. PMID 20456001 DOI: 10.1111/j.1471-4159.2010.06771.x  1
2010 Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 291-6. PMID 20451879 DOI: 10.1016/j.jalz.2010.03.009  1
2010 Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, Barnham KJ. Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 6315-22. PMID 20445057 DOI: 10.1523/JNEUROSCI.5180-09.2010  1
2010 Nisbet RM, Harrison CF, Lawson VA, Masters CL, Cappai R, Hill AF. Residues surrounding the glycosylphosphatidylinositol anchor attachment site of PrP modulate prion infection: insight from the resistance of rabbits to prion disease. Journal of Virology. 84: 6678-86. PMID 20427543 DOI: 10.1128/JVI.02709-09  1
2010 Lui JK, Laws SM, Li QX, Villemagne VL, Ames D, Brown B, Bush AI, De Ruyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, ... ... Masters CL, et al. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. Journal of Alzheimer's Disease : Jad. 20: 1233-42. PMID 20413897 DOI: 10.3233/JAD-2010-090249  1
2010 Perreau VM, Orchard S, Adlard PA, Bellingham SA, Cappai R, Ciccotosto GD, Cowie TF, Crouch PJ, Duce JA, Evin G, Faux NG, Hill AF, Hung YH, James SA, Li QX, ... ... Masters CL, et al. A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease. Proteomics. 10: 2377-95. PMID 20391539 DOI: 10.1002/pmic.200900773  1
2010 Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology. 67: 317-24. PMID 20373343 DOI: 10.1002/ana.21955  1
2010 Harrison CF, Lawson VA, Coleman BM, Kim YS, Masters CL, Cappai R, Barnham KJ, Hill AF. Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity. The Journal of Biological Chemistry. 285: 20213-23. PMID 20356832 DOI: 10.1074/jbc.M109.093310  1
2010 Rekas A, Knott RB, Sokolova A, Barnham KJ, Perez KA, Masters CL, Drew SC, Cappai R, Curtain CC, Pham CL. The structure of dopamine induced alpha-synuclein oligomers. European Biophysics Journal : Ebj. 39: 1407-19. PMID 20309679 DOI: 10.1007/s00249-010-0595-x  1
2010 Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A, Bedo J, Harrison J, Lannfelt L, Blennow K, Zetterberg H, Ingelsson M, Masters CL, Tanzi RE, Cummings JL, Herd CM, et al. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. Journal of Alzheimer's Disease : Jad. 20: 509-16. PMID 20164561 DOI: 10.3233/JAD-2010-1390  1
2010 Caragounis A, Price KA, Soon CP, Filiz G, Masters CL, Li QX, Crouch PJ, White AR. Zinc induces depletion and aggregation of endogenous TDP-43. Free Radical Biology & Medicine. 48: 1152-61. PMID 20138212 DOI: 10.1016/j.freeradbiomed.2010.01.035  1
2010 Villemagne VL, Pike K, Pejoska S, Boyd A, Power M, Jones G, Masters CL, Rowe CC. 11C-PiB PET ABri imaging in Worster-Drought syndrome (familial British dementia): a case report. Journal of Alzheimer's Disease : Jad. 19: 423-8. PMID 20110591 DOI: 10.3233/JAD-2010-1241  1
2010 Soon CP, Crouch PJ, Turner BJ, McLean CA, Laughton KM, Atkin JD, Masters CL, White AR, Li QX. Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice. Neuromuscular Disorders : Nmd. 20: 260-6. PMID 20097566 DOI: 10.1016/j.nmd.2009.11.015  1
2010 Boon WC, van den Buuse M, Wegener N, Martin S, Chua HK, Bush AI, Masters CL, Adlard PA, Li QX. Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Abeta-bearing fragment is associated with reduced NMDA receptor density. Behavioural Brain Research. 209: 27-35. PMID 20085783 DOI: 10.1016/j.bbr.2010.01.013  1
2010 Bourgeat P, Chételat G, Villemagne VL, Fripp J, Raniga P, Pike K, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O, et al. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology. 74: 121-7. PMID 20065247 DOI: 10.1212/WNL.0b013e3181c918b5  1
2010 Smith DG, Ciccotosto GD, Tew DJ, Perez K, Curtain CC, Boas JF, Masters CL, Cappai R, Barnham KJ. Histidine 14 modulates membrane binding and neurotoxicity of the Alzheimer's disease amyloid-beta peptide. Journal of Alzheimer's Disease : Jad. 19: 1387-400. PMID 20061603 DOI: 10.3233/JAD-2010-1334  0.52
2010 Guipponi M, Li QX, Hyde L, Beissbarth T, Smyth GK, Masters CL, Scott HS. SAGE analysis of genes differentially expressed in presymptomatic TgSOD1G93A transgenic mice identified cellular processes involved in early stage of ALS pathology. Journal of Molecular Neuroscience : Mn. 41: 172-82. PMID 19953340 DOI: 10.1007/s12031-009-9317-1  0.64
2010 George AJ, Gordon L, Beissbarth T, Koukoulas I, Holsinger RM, Perreau V, Cappai R, Tan SS, Masters CL, Scott HS, Li QX. A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model. Neurotoxicity Research. 17: 360-79. PMID 19760337 DOI: 10.1007/s12640-009-9112-3  0.64
2009 Okamura N, Fodero-Tavoletti MT, Kudo Y, Rowe CC, Furumoto S, Arai H, Masters CL, Yanai K, Villemagne VL. Advances in molecular imaging for the diagnosis of dementia. Expert Opinion On Medical Diagnostics. 3: 705-16. PMID 23496052 DOI: 10.1517/17530050903133790  1
2009 Fodero-Tavoletti MT, Cappai R, McLean CA, Pike KE, Adlard PA, Cowie T, Connor AR, Masters CL, Rowe CC, Villemagne VL. Amyloid imaging in Alzheimer's disease and other dementias. Brain Imaging and Behavior. 3: 246-61. PMID 22005989 DOI: 10.1007/s11682-009-9067-2  1
2009 Villemagne VL, Ataka S, Mizuno T, Brooks WS, Wada Y, Kondo M, Jones G, Watanabe Y, Mulligan R, Nakagawa M, Miki T, Shimada H, O'Keefe GJ, Masters CL, Mori H, et al. High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Archives of Neurology. 66: 1537-44. PMID 20008660 DOI: 10.1001/archneurol.2009.285  1
2009 Lewis V, Hill AF, Haigh CL, Klug GM, Masters CL, Lawson VA, Collins SJ. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection. Journal of Neuropathology and Experimental Neurology. 68: 1125-35. PMID 19918124 DOI: 10.1097/NEN.0b013e3181b96981  1
2009 Evered LA, Silbert BS, Scott DA, Maruff P, Laughton KM, Volitakis I, Cowie T, Cherny RA, Masters CL, Li QX. Plasma amyloid beta42 and amyloid beta40 levels are associated with early cognitive dysfunction after cardiac surgery. The Annals of Thoracic Surgery. 88: 1426-32. PMID 19853085 DOI: 10.1016/j.athoracsur.2009.07.003  1
2009 Tinsley RB, Bye CR, Parish CL, Tziotis-Vais A, George S, Culvenor JG, Li QX, Masters CL, Finkelstein DI, Horne MK. Dopamine D2 receptor knockout mice develop features of Parkinson disease. Annals of Neurology. 66: 472-84. PMID 19847912 DOI: 10.1002/ana.21716  0.64
2009 Price KA, Caragounis A, Paterson BM, Filiz G, Volitakis I, Masters CL, Barnham KJ, Donnelly PS, Crouch PJ, White AR. Sustained activation of glial cell epidermal growth factor receptor by bis(thiosemicarbazonato) metal complexes is associated with inhibition of protein tyrosine phosphatase activity. Journal of Medicinal Chemistry. 52: 6606-20. PMID 19807095 DOI: 10.1021/jm9007938  1
2009 Brazier MW, Wall VA, Brazier BW, Masters CL, Collins SJ. Therapeutic interventions ameliorating prion disease. Expert Review of Anti-Infective Therapy. 7: 83-105. PMID 19622059 DOI: 10.1586/14787210.7.1.83  1
2009 Goldfarb LG, Vladimirtsev VA, Platanov FA, Lee HS, McLean CA, Masters CL. Viliuisk encephalomyelitis in Eastern Siberia - analysis of 390 cases. Folia Neuropathologica / Association of Polish Neuropathologists and Medical Research Centre, Polish Academy of Sciences. 47: 171-81. PMID 19618339  1
2009 Haigh CL, Lewis VA, Vella LJ, Masters CL, Hill AF, Lawson VA, Collins SJ. PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site. Cell Research. 19: 1062-78. PMID 19597535 DOI: 10.1038/cr.2009.86  1
2009 Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, Masters CL, Cappai R, Yanai K, Villemagne VL. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies. European Journal of Pharmacology. 617: 54-8. PMID 19576880 DOI: 10.1016/j.ejphar.2009.06.042  1
2009 McColl G, Roberts BR, Gunn AP, Perez KA, Tew DJ, Masters CL, Barnham KJ, Cherny RA, Bush AI. The Caenorhabditis elegans A beta 1-42 model of Alzheimer disease predominantly expresses A beta 3-42. The Journal of Biological Chemistry. 284: 22697-702. PMID 19574211 DOI: 10.1074/jbc.C109.028514  1
2009 Hung YH, Robb EL, Volitakis I, Ho M, Evin G, Li QX, Culvenor JG, Masters CL, Cherny RA, Bush AI. Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. The Journal of Biological Chemistry. 284: 21899-907. PMID 19542222 DOI: 10.1074/jbc.M109.019521  1
2009 Adlard PA, James SA, Bush AI, Masters CL. beta-Amyloid as a molecular therapeutic target in Alzheimer's disease. Drugs of Today (Barcelona, Spain : 1998). 45: 293-304. PMID 19499094 DOI: 10.1358/dot.2009.45.4.1353853  1
2009 Drew SC, Masters CL, Barnham KJ. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms. Journal of the American Chemical Society. 131: 8760-1. PMID 19496610 DOI: 10.1021/ja903669a  0.48
2009 Haigh CL, Drew SC, Boland MP, Masters CL, Barnham KJ, Lawson VA, Collins SJ. Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection response. Journal of Cell Science. 122: 1518-28. PMID 19383722 DOI: 10.1242/jcs.043604  0.72
2009 Maynard CJ, Cappai R, Volitakis I, Laughton KM, Masters CL, Bush AI, Li QX. Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice. Cellular and Molecular Neurobiology. 29: 757-67. PMID 19381799 DOI: 10.1007/s10571-009-9401-7  1
2009 Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG. Abeta aggregation and possible implications in Alzheimer's disease pathogenesis. Journal of Cellular and Molecular Medicine. 13: 412-21. PMID 19374683 DOI: 10.1111/j.1582-4934.2009.00609.x  1
2009 Villemagne VL, McLean CA, Reardon K, Boyd A, Lewis V, Klug G, Jones G, Baxendale D, Masters CL, Rowe CC, Collins SJ. 11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery, and Psychiatry. 80: 998-1001. PMID 19332421 DOI: 10.1136/jnnp.2008.171496  1
2009 Smith JP, Lal V, Bowser D, Cappai R, Masters CL, Ciccotosto GD. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices. Brain Research. 1269: 176-84. PMID 19302985 DOI: 10.1016/j.brainres.2009.03.007  1
2009 Price KA, Crouch PJ, Donnelly PS, Masters CL, White AR, Curtain CC. Membrane-targeted strategies for modulating APP and Abeta-mediated toxicity. Journal of Cellular and Molecular Medicine. 13: 249-61. PMID 19278455 DOI: 10.1111/j.1582-4934.2008.00642.x  1
2009 Dutescu RM, Li QX, Crowston J, Masters CL, Baird PN, Culvenor JG. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv FüR Klinische Und Experimentelle Ophthalmologie. 247: 1213-21. PMID 19271231 DOI: 10.1007/s00417-009-1060-3  1
2009 Leong SL, Pham CL, Galatis D, Fodero-Tavoletti MT, Perez K, Hill AF, Masters CL, Ali FE, Barnham KJ, Cappai R. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation. Free Radical Biology & Medicine. 46: 1328-37. PMID 19248830 DOI: 10.1016/j.freeradbiomed.2009.02.009  1
2009 Fodero-Tavoletti MT, Rowe CC, McLean CA, Leone L, Li QX, Masters CL, Cappai R, Villemagne VL. Characterization of PiB binding to white matter in Alzheimer disease and other dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 198-204. PMID 19164220 DOI: 10.2967/jnumed.108.057984  1
2009 Crouch PJ, Tew DJ, Du T, Nguyen DN, Caragounis A, Filiz G, Blake RE, Trounce IA, Soon CP, Laughton K, Perez KA, Li QX, Cherny RA, Masters CL, Barnham KJ, et al. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation. Journal of Neurochemistry. 108: 1198-207. PMID 19141082 DOI: 10.1111/j.1471-4159.2009.05870.x  1
2009 Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, Filiz G, Perez KA, Nurjono M, Caragounis A, Du T, Laughton K, Volitakis I, Bush AI, Li QX, Masters CL, et al. Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proceedings of the National Academy of Sciences of the United States of America. 106: 381-6. PMID 19122148 DOI: 10.1073/pnas.0809057106  1
2009 Drew SC, Noble CJ, Masters CL, Hanson GR, Barnham KJ. Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide. Journal of the American Chemical Society. 131: 1195-207. PMID 19119811 DOI: 10.1021/ja808073b  1
2009 Biran Y, Masters CL, Barnham KJ, Bush AI, Adlard PA. Pharmacotherapeutic targets in Alzheimer's disease. Journal of Cellular and Molecular Medicine. 13: 61-86. PMID 19040415 DOI: 10.1111/j.1582-4934.2008.00595.x  1
2009 Bellingham SA, Coleman LA, Masters CL, Camakaris J, Hill AF. Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. The Journal of Biological Chemistry. 284: 1291-301. PMID 18990686 DOI: 10.1074/jbc.M804755200  1
2009 Robert R, Dolezal O, Waddington L, Hattarki MK, Cappai R, Masters CL, Hudson PJ, Wark KL. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers. Protein Engineering, Design & Selection : Peds. 22: 199-208. PMID 18927231 DOI: 10.1093/protein/gzn052  0.52
2009 Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. Molecular Psychiatry. 14: 469-86. PMID 18794889 DOI: 10.1038/mp.2008.96  1
2008 Hung LW, Ciccotosto GD, Giannakis E, Tew DJ, Perez K, Masters CL, Cappai R, Wade JD, Barnham KJ. Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 11950-8. PMID 19005060 DOI: 10.1523/JNEUROSCI.3916-08.2008  0.52
2008 Raniga P, Bourgeat P, Fripp J, Acosta O, Villemagne VL, Rowe C, Masters CL, Jones G, O'Keefe G, Salvado O, Ourselin S. Automated (11)C-PiB standardized uptake value ratio. Academic Radiology. 15: 1376-89. PMID 18995189 DOI: 10.1016/j.acra.2008.07.006  1
2008 Fripp J, Bourgeat P, Acosta O, Raniga P, Modat M, Pike KE, Jones G, O'Keefe G, Masters CL, Ames D, Ellis KA, Maruff P, Currie J, Villemagne VL, Rowe CC, et al. Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging. Neuroimage. 43: 430-9. PMID 18789389 DOI: 10.1016/j.neuroimage.2008.07.053  1
2008 Klug GM, Boyd A, Lewis V, McGlade AR, Roberts H, Douglass SL, Masters CL, Collins SJ. Surveillance of Creutzfeldt-Jakob disease in Australia: 2008. Communicable Diseases Intelligence Quarterly Report. 32: 232-6. PMID 18767422  1
2008 Villemagne VL, Fodero-Tavoletti MT, Pike KE, Cappai R, Masters CL, Rowe CC. The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias. Molecular Neurobiology. 38: 1-15. PMID 18690556 DOI: 10.1007/s12035-008-8019-y  0.52
2008 Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J, Masters CL, Targum S, Bush AI, Murdoch R, Wilson J, Ritchie CW. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. The Lancet. Neurology. 7: 779-86. PMID 18672400 DOI: 10.1016/S1474-4422(08)70167-4  1
2008 Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O'Keefe G, NÃ¥gren K, Chaudhury KR, Masters CL, Brooks DJ. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 79: 1331-8. PMID 18653550 DOI: 10.1136/jnnp.2007.127878  0.32
2008 Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E, Cortes M, Volitakis I, Liu X, Smith JP, Perez K, Laughton K, Li QX, Charman SA, Nicolazzo JA, Wilkins S, ... ... Masters CL, et al. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron. 59: 43-55. PMID 18614028 DOI: 10.1016/j.neuron.2008.06.018  1
2008 Streltsov VA, Titmuss SJ, Epa VC, Barnham KJ, Masters CL, Varghese JN. The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease. Biophysical Journal. 95: 3447-56. PMID 18599641 DOI: 10.1529/biophysj.108.134429  0.48
2008 Lawson VA, Vella LJ, Stewart JD, Sharples RA, Klemm H, Machalek DM, Masters CL, Cappai R, Collins SJ, Hill AF. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture. The International Journal of Biochemistry & Cell Biology. 40: 2793-801. PMID 18590830 DOI: 10.1016/j.biocel.2008.05.024  1
2008 Drew SC, Leong SL, Pham CL, Tew DJ, Masters CL, Miles LA, Cappai R, Barnham KJ. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy. Journal of the American Chemical Society. 130: 7766-73. PMID 18494470 DOI: 10.1021/ja800708x  0.52
2008 Barnham KJ, Kenche VB, Ciccotosto GD, Smith DP, Tew DJ, Liu X, Perez K, Cranston GA, Johanssen TJ, Volitakis I, Bush AI, Masters CL, White AR, Smith JP, Cherny RA, et al. Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 105: 6813-8. PMID 18463291 DOI: 10.1073/pnas.0800712105  1
2008 Brazier MW, Doctrow SR, Masters CL, Collins SJ. A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease. Free Radical Biology & Medicine. 45: 184-92. PMID 18455516 DOI: 10.1016/j.freeradbiomed.2008.04.006  1
2008 Wun KS, Miles LA, Crespi GA, Wycherley K, Ascher DB, Barnham KJ, Cappai R, Beyreuther K, Masters CL, Parker MW, McKinstry WJ. Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 64: 438-41. PMID 18453721 DOI: 10.1107/S1744309108011718  1
2008 Needham BE, Wlodek ME, Ciccotosto GD, Fam BC, Masters CL, Proietto J, Andrikopoulos S, Cappai R. Identification of the Alzheimer's disease amyloid precursor protein (APP) and its homologue APLP2 as essential modulators of glucose and insulin homeostasis and growth. The Journal of Pathology. 215: 155-63. PMID 18393365 DOI: 10.1002/path.2343  0.52
2008 Du T, La Fontaine SL, Abdo M, Bellingham SA, Greenough M, Volitakis I, Cherny RA, Bush AI, Hudson PJ, Camakaris J, Mercer JF, Crouch PJ, Masters CL, Perreau VM, White AR. Investigating copper-regulated protein expression in Menkes fibroblasts using antibody microarrays. Proteomics. 8: 1819-31. PMID 18384105 DOI: 10.1002/pmic.200700895  1
2008 Price KA, Filiz G, Caragounis A, Du T, Laughton KM, Masters CL, Sharples RA, Hill AF, Li QX, Donnelly PS, Barnham KJ, Crouch PJ, White AR. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide. The International Journal of Biochemistry & Cell Biology. 40: 1901-17. PMID 18346929 DOI: 10.1016/j.biocel.2008.01.033  1
2008 Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, Ackermann U, Cowie TF, Currie J, Chan SG, Jones G, Tochon-Danguy H, O'Keefe G, Masters CL, Rowe CC. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsychologia. 46: 1688-97. PMID 18343463 DOI: 10.1016/j.neuropsychologia.2008.02.008  1
2008 George S, van den Buuse M, San Mok S, Masters CL, Li QX, Culvenor JG. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Experimental Neurology. 210: 788-92. PMID 18295208 DOI: 10.1016/j.expneurol.2007.12.017  0.64
2008 Giannakis E, Pacífico J, Smith DP, Hung LW, Masters CL, Cappai R, Wade JD, Barnham KJ. Dimeric structures of alpha-synuclein bind preferentially to lipid membranes. Biochimica Et Biophysica Acta. 1778: 1112-9. PMID 18261456 DOI: 10.1016/j.bbamem.2008.01.012  0.52
2008 Miles LA, Wun KS, Crespi GA, Fodero-Tavoletti MT, Galatis D, Bagley CJ, Beyreuther K, Masters CL, Cappai R, McKinstry WJ, Barnham KJ, Parker MW. Amyloid-beta-anti-amyloid-beta complex structure reveals an extended conformation in the immunodominant B-cell epitope. Journal of Molecular Biology. 377: 181-92. PMID 18237744 DOI: 10.1016/j.jmb.2007.12.036  1
2008 Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O'Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, ... ... Masters CL, et al. Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. The Lancet. Neurology. 7: 129-35. PMID 18191617 DOI: 10.1016/S1474-4422(08)70001-2  1
2008 Smith DP, Tew DJ, Hill AF, Bottomley SP, Masters CL, Barnham KJ, Cappai R. Formation of a high affinity lipid-binding intermediate during the early aggregation phase of alpha-synuclein. Biochemistry. 47: 1425-34. PMID 18179253 DOI: 10.1021/bi701522m  1
2008 Sharples RA, Vella LJ, Nisbet RM, Naylor R, Perez K, Barnham KJ, Masters CL, Hill AF. Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 1469-78. PMID 18171695 DOI: 10.1096/fj.07-9357com  1
2008 Filiz G, Caragounis A, Bica L, Du T, Masters CL, Crouch PJ, White AR. Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity. The International Journal of Biochemistry & Cell Biology. 40: 1030-42. PMID 18160328 DOI: 10.1016/j.biocel.2007.11.003  0.48
2008 Donnelly PS, Caragounis A, Du T, Laughton KM, Volitakis I, Cherny RA, Sharples RA, Hill AF, Li QX, Masters CL, Barnham KJ, White AR. Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide. The Journal of Biological Chemistry. 283: 4568-77. PMID 18086681 DOI: 10.1074/jbc.M705957200  1
2008 Tew DJ, Bottomley SP, Smith DP, Ciccotosto GD, Babon J, Hinds MG, Masters CL, Cappai R, Barnham KJ. Stabilization of neurotoxic soluble beta-sheet-rich conformations of the Alzheimer's disease amyloid-beta peptide. Biophysical Journal. 94: 2752-66. PMID 18065467 DOI: 10.1529/biophysj.107.119909  0.52
2008 Du T, Ciccotosto GD, Cranston GA, Kocak G, Masters CL, Crouch PJ, Cappai R, White AR. Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activation. Free Radical Biology & Medicine. 44: 44-55. PMID 18045546 DOI: 10.1016/j.freeradbiomed.2007.09.001  0.52
2008 Crouch PJ, Harding SM, White AR, Camakaris J, Bush AI, Masters CL. Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease. The International Journal of Biochemistry & Cell Biology. 40: 181-98. PMID 17804276 DOI: 10.1016/j.biocel.2007.07.013  1
2007 Vladimirtsev VA, Nikitina RS, Renwick N, Ivanova AA, Danilova AP, Platonov FA, Krivoshapkin VG, McLean CA, Masters CL, Gajdusek DC, Goldfarb LG. Family clustering of Viliuisk encephalomyelitis in traditional and new geographic regions. Emerging Infectious Diseases. 13: 1321-6. PMID 18252102 DOI: 10.3201/eid1309.061585  1
2007 Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, Mathis CA, Klunk WE, Masters CL, Rowe CC. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain : a Journal of Neurology. 130: 2837-44. PMID 17928318 DOI: 10.1093/brain/awm238  0.32
2007 Lau TL, Gehman JD, Wade JD, Masters CL, Barnham KJ, Separovic F. Cholesterol and Clioquinol modulation of A beta(1-42) interaction with phospholipid bilayers and metals. Biochimica Et Biophysica Acta. 1768: 3135-44. PMID 17920561 DOI: 10.1016/j.bbamem.2007.08.027  1
2007 Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, Leone L, Perez K, Cortés M, Culvenor JG, Li QX, Laughton KM, Rowe CC, Masters CL, Cappai R, et al. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 10365-71. PMID 17898208 DOI: 10.1523/JNEUROSCI.0630-07.2007  0.64
2007 Lawson VA, Stewart JD, Masters CL. Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. The Journal of General Virology. 88: 2905-14. PMID 17872546 DOI: 10.1099/vir.0.82961-0  1
2007 Klug GM, Boyd A, Lewis V, Douglass SL, Roberts H, Argent R, Masters CL, Collins SJ. Creutzfeldt-Jakob disease: Australian surveillance update to March 2007. Communicable Diseases Intelligence Quarterly Report. 31: 194-7. PMID 17724994  1
2007 Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD. A primer of amyloid nomenclature. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 179-83. PMID 17701465 DOI: 10.1080/13506120701460923  1
2007 Ng SY, Villemagne VL, Masters CL, Rowe CC. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. Archives of Neurology. 64: 1140-4. PMID 17698704 DOI: 10.1001/archneur.64.8.1140  1
2007 Caragounis A, Du T, Filiz G, Laughton KM, Volitakis I, Sharples RA, Cherny RA, Masters CL, Drew SC, Hill AF, Li QX, Crouch PJ, Barnham KJ, White AR. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands. The Biochemical Journal. 407: 435-50. PMID 17680773 DOI: 10.1042/BJ20070579  1
2007 Melrose HL, Kent CB, Taylor JP, Dachsel JC, Hinkle KM, Lincoln SJ, Mok SS, Culvenor JG, Masters CL, Tyndall GM, Bass DI, Ahmed Z, Andorfer CA, Ross OA, Wszolek ZK, et al. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience. 147: 1047-58. PMID 17611037 DOI: 10.1016/j.neuroscience.2007.05.027  1
2007 Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, Schilling B, Mavros C, Masters CL, Volitakis I, Li QX, Laughton K, Hubbard A, Cherny RA, Gibson B, et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. Plos One. 2: e536. PMID 17579710 DOI: 10.1371/journal.pone.0000536  1
2007 Lau TL, Gehman JD, Wade JD, Perez K, Masters CL, Barnham KJ, Separovic F. Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42). Biochimica Et Biophysica Acta. 1768: 2400-8. PMID 17574205 DOI: 10.1016/j.bbamem.2007.05.004  1
2007 Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, ... ... Masters CL, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 68: 1718-25. PMID 17502554 DOI: 10.1212/01.wnl.0000261919.22630.ea  1
2007 Ng S, Villemagne VL, Berlangieri S, Lee ST, Cherk M, Gong SJ, Ackermann U, Saunder T, Tochon-Danguy H, Jones G, Smith C, O'Keefe G, Masters CL, Rowe CC. Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 547-52. PMID 17401090  0.32
2007 Vella LJ, Sharples RA, Lawson VA, Masters CL, Cappai R, Hill AF. Packaging of prions into exosomes is associated with a novel pathway of PrP processing. The Journal of Pathology. 211: 582-90. PMID 17334982 DOI: 10.1002/path.2145  1
2007 Smith DP, Ciccotosto GD, Tew DJ, Fodero-Tavoletti MT, Johanssen T, Masters CL, Barnham KJ, Cappai R. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide. Biochemistry. 46: 2881-91. PMID 17297919 DOI: 10.1021/bi0620961  0.52
2007 Li QX, Mok SS, Laughton KM, McLean CA, Cappai R, Masters CL, Culvenor JG, Horne MK. Plasma alpha-synuclein is decreased in subjects with Parkinson's disease. Experimental Neurology. 204: 583-8. PMID 17258710 DOI: 10.1016/j.expneurol.2006.12.006  1
2007 Kong GK, Adams JJ, Harris HH, Boas JF, Curtain CC, Galatis D, Masters CL, Barnham KJ, McKinstry WJ, Cappai R, Parker MW. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions. Journal of Molecular Biology. 367: 148-61. PMID 17239395 DOI: 10.1016/j.jmb.2006.12.041  1
2006 Villemagne VL, Ng S, Cappai R, Barnham KJ, Fodero-Tavoletti MT, Rowe CC, Masters CL. La lunga attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease. The Neuroradiology Journal. 19: 453-74. PMID 24351248  0.52
2006 Masters CL, Beyreuther K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain : a Journal of Neurology. 129: 2823-39. PMID 17012295 DOI: 10.1093/brain/awl251  1
2006 Sim CH, Lio DS, Mok SS, Masters CL, Hill AF, Culvenor JG, Cheng HC. C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Human Molecular Genetics. 15: 3251-62. PMID 17000703 DOI: 10.1093/hmg/ddl398  1
2006 Crouch PJ, Barnham KJ, Duce JA, Blake RE, Masters CL, Trounce IA. Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide. Journal of Neurochemistry. 99: 226-36. PMID 16987248 DOI: 10.1111/j.1471-4159.2006.04050.x  1
2006 Masters CL, Beyreuther K. Pathways to the discovery of the Abeta amyloid of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 155-61. PMID 16914854  1
2006 Duce JA, Smith DP, Blake RE, Crouch PJ, Li QX, Masters CL, Trounce IA. Linker histone H1 binds to disease associated amyloid-like fibrils. Journal of Molecular Biology. 361: 493-505. PMID 16854430 DOI: 10.1016/j.jmb.2006.06.038  1
2006 Barnham KJ, Cappai R, Beyreuther K, Masters CL, Hill AF. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends in Biochemical Sciences. 31: 465-72. PMID 16820299 DOI: 10.1016/j.tibs.2006.06.006  1
2006 Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain : a Journal of Neurology. 129: 2278-87. PMID 16816392 DOI: 10.1093/brain/awl159  1
2006 Masters CL, Cappai R, Barnham KJ, Villemagne VL. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. Journal of Neurochemistry. 97: 1700-25. PMID 16805778 DOI: 10.1111/j.1471-4159.2006.03989.x  0.52
2006 Koh CH, Whiteman M, Li QX, Halliwell B, Jenner AM, Wong BS, Laughton KM, Wenk M, Masters CL, Beart PM, Bernard O, Cheung NS. Chronic exposure to U18666A is associated with oxidative stress in cultured murine cortical neurons. Journal of Neurochemistry. 98: 1278-89. PMID 16771828 DOI: 10.1111/j.1471-4159.2006.03958.x  1
2006 Evin G, Sernee MF, Masters CL. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies. Cns Drugs. 20: 351-72. PMID 16696577  0.68
2006 White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE, Holsinger RM, Evin G, Cherny RA, Hill AF, Barnham KJ, Li QX, Bush AI, Masters CL. Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. The Journal of Biological Chemistry. 281: 17670-80. PMID 16648635 DOI: 10.1074/jbc.M602487200  1
2006 Klug GM, Boyd A, Lewis V, Douglass SL, Argent R, Lee JS, Masters CL, Collins SJ. Creutzfeldt-Jakob disease: Australian surveillance update to December 2005. Communicable Diseases Intelligence Quarterly Report. 30: 144-7. PMID 16637244  1
2006 Li QX, Mok SS, Laughton KM, McLean CA, Volitakis I, Cherny RA, Cheung NS, White AR, Masters CL. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model. Aging Cell. 5: 153-65. PMID 16626394 DOI: 10.1111/j.1474-9726.2006.00200.x  1
2006 Smith DP, Smith DG, Curtain CC, Boas JF, Pilbrow JR, Ciccotosto GD, Lau TL, Tew DJ, Perez K, Wade JD, Bush AI, Drew SC, Separovic F, Masters CL, Cappai R, et al. Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridge. The Journal of Biological Chemistry. 281: 15145-54. PMID 16595673 DOI: 10.1074/jbc.M600417200  0.52
2006 Maynard CJ, Cappai R, Volitakis I, Cherny RA, Masters CL, Li QX, Bush AI. Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology. Journal of Inorganic Biochemistry. 100: 952-62. PMID 16574231 DOI: 10.1016/j.jinorgbio.2006.02.010  0.64
2006 Andersen OM, Schmidt V, Spoelgen R, Gliemann J, Behlke J, Galatis D, McKinstry WJ, Parker MW, Masters CL, Hyman BT, Cappai R, Willnow TE. Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. Biochemistry. 45: 2618-28. PMID 16489755 DOI: 10.1021/bi052120v  0.52
2006 Opazo C, Luza S, Villemagne VL, Volitakis I, Rowe C, Barnham KJ, Strozyk D, Masters CL, Cherny RA, Bush AI. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease. Aging Cell. 5: 69-79. PMID 16441845 DOI: 10.1111/j.1474-9726.2006.00196.x  0.52
2006 Gralle M, Oliveira CL, Guerreiro LH, McKinstry WJ, Galatis D, Masters CL, Cappai R, Parker MW, Ramos CH, Torriani I, Ferreira ST. Solution conformation and heparin-induced dimerization of the full-length extracellular domain of the human amyloid precursor protein. Journal of Molecular Biology. 357: 493-508. PMID 16436282 DOI: 10.1016/j.jmb.2005.12.053  1
2006 Lau TL, Ambroggio EE, Tew DJ, Cappai R, Masters CL, Fidelio GD, Barnham KJ, Separovic F. Amyloid-beta peptide disruption of lipid membranes and the effect of metal ions. Journal of Molecular Biology. 356: 759-70. PMID 16403524 DOI: 10.1016/j.jmb.2005.11.091  0.52
2006 Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL, Hill AF, White AR, Collins S. Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Research Bulletin. 68: 346-54. PMID 16377442 DOI: 10.1016/j.brainresbull.2005.09.010  1
2006 Mok SS, Losic D, Barrow CJ, Turner BJ, Masters CL, Martin LL, Small DH. The beta-amyloid peptide of Alzheimer's disease decreases adhesion of vascular smooth muscle cells to the basement membrane. Journal of Neurochemistry. 96: 53-64. PMID 16269005 DOI: 10.1111/j.1471-4159.2005.03539.x  1
2005 Kong GK, Galatis D, Barnham KJ, Polekhina G, Adams JJ, Masters CL, Cappai R, Parker MW, McKinstry WJ. Crystallization and preliminary crystallographic studies of the copper-binding domain of the amyloid precursor protein of Alzheimer's disease. Acta Crystallographica. Section F, Structural Biology and Crystallization Communications. 61: 93-5. PMID 16508101 DOI: 10.1107/S1744309104029744  0.52
2005 Yuan FF, Biffin S, Brazier MW, Suarez M, Cappai R, Hill AF, Collins SJ, Sullivan JS, Middleton D, Multhaup G, Geczy AF, Masters CL. Detection of prion epitopes on PrP and PrP of transmissible spongiform encephalopathies using specific monoclonal antibodies to PrP. Immunology and Cell Biology. 83: 632-7. PMID 16266315 DOI: 10.1111/j.1440-1711.2005.01384.x  1
2005 Hoke DE, Tan JL, Ilaya NT, Culvenor JG, Smith SJ, White AR, Masters CL, Evin GM. In vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc. The Febs Journal. 272: 5544-57. PMID 16262694 DOI: 10.1111/j.1742-4658.2005.04950.x  0.48
2005 Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, Löwer A, Langer A, Merdes G, Paro R, Masters CL, Müller U, Kins S, Beyreuther K. Homo- and heterodimerization of APP family members promotes intercellular adhesion. The Embo Journal. 24: 3624-34. PMID 16193067 DOI: 10.1038/sj.emboj.7600824  1
2004 Barnham KJ, Haeffner F, Ciccotosto GD, Curtain CC, Tew D, Mavros C, Beyreuther K, Carrington D, Masters CL, Cherny RA, Cappai R, Bush AI. Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 1427-9. PMID 15231727 DOI: 10.1096/fj.04-1890fje  1
2004 George AJ, Holsinger RM, McLean CA, Laughton KM, Beyreuther K, Evin G, Masters CL, Li QX. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiology of Disease. 16: 124-32. PMID 15207269 DOI: 10.1016/j.nbd.2004.01.009  1
2004 Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A, Beyreuther K. The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. The Journal of Biological Chemistry. 279: 18146-56. PMID 14970212 DOI: 10.1074/jbc.M311601200  1
2004 White AR, Barnham KJ, Huang X, Voltakis I, Beyreuther K, Masters CL, Cherny RA, Bush AI, Cappai R. Iron inhibits neurotoxicity induced by trace copper and biological reductants. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. 9: 269-80. PMID 14758525 DOI: 10.1007/s00775-004-0521-8  1
2003 Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M, MacGregor L, Kiers L, Cherny R, Li QX, Tammer A, Carrington D, Mavros C, Volitakis I, Xilinas M, Ames D, ... ... Masters CL, et al. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Archives of Neurology. 60: 1685-91. PMID 14676042 DOI: 10.1001/archneur.60.12.1685  1
2003 White AR, Maher F, Brazier MW, Jobling MF, Thyer J, Stewart LR, Thompson A, Gibson R, Masters CL, Multhaup G, Beyreuther K, Barrow CJ, Collins SJ, Cappai R. Diverse fibrillar peptides directly bind the Alzheimer's amyloid precursor protein and amyloid precursor-like protein 2 resulting in cellular accumulation. Brain Research. 966: 231-44. PMID 12618346 DOI: 10.1016/S0006-8993(02)04173-2  1
2003 Barnham KJ, McKinstry WJ, Multhaup G, Galatis D, Morton CJ, Curtain CC, Williamson NA, White AR, Hinds MG, Norton RS, Beyreuther K, Masters CL, Parker MW, Cappai R. Structure of the Alzheimer's disease amyloid precursor protein copper binding domain. A regulator of neuronal copper homeostasis. The Journal of Biological Chemistry. 278: 17401-7. PMID 12611883 DOI: 10.1074/jbc.M300629200  1
2003 Sernee MF, Evin G, Culvenor JG, Villadangos JA, Beyreuther K, Masters CL, Cappai R. Selecting cells with different Alzheimer's disease gamma-secretase activity using FACS. Differential effect on presenilin exon 9 gamma- and epsilon-cleavage. European Journal of Biochemistry / Febs. 270: 495-506. PMID 12542699 DOI: 10.1046/j.1432-1033.2003.03405.x  1
2003 Grziwa B, Grimm MO, Masters CL, Beyreuther K, Hartmann T, Lichtenthaler SF. The transmembrane domain of the amyloid precursor protein in microsomal membranes is on both sides shorter than predicted. The Journal of Biological Chemistry. 278: 6803-8. PMID 12454010 DOI: 10.1074/jbc.M210047200  1
2002 Khalil Z, Poliviou H, Maynard CJ, Beyreuther K, Masters CL, Li QX. Mechanisms of peripheral microvascular dysfunction in transgenic mice overexpressing the Alzheimer's disease amyloid Abeta protein. Journal of Alzheimer's Disease : Jad. 4: 467-78. PMID 12515898  1
2002 Li QX, Campbell BC, McLean CA, Thyagarajan D, Gai WP, Kapsa RM, Beyreuther K, Masters CL, Culvenor JG. Platelet alpha- and gamma-synucleins in Parkinson's disease and normal control subjects. Journal of Alzheimer's Disease : Jad. 4: 309-15. PMID 12446933  1
2002 Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL, Bush AI, Li QX. Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. The Journal of Biological Chemistry. 277: 44670-6. PMID 12215434 DOI: 10.1074/jbc.M204379200  1
2002 Simons A, Ruppert T, Schmidt C, Schlicksupp A, Pipkorn R, Reed J, Masters CL, White AR, Cappai R, Beyreuther K, Bayer TA, Multhaup G. Evidence for a copper-binding superfamily of the amyloid precursor protein. Biochemistry. 41: 9310-20. PMID 12135352 DOI: 10.1021/bi0258647  1
2002 Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Annals of Neurology. 51: 783-6. PMID 12112088 DOI: 10.1002/ana.10208  1
2002 Mok SS, Turner BJ, Beyreuther K, Masters CL, Barrow CJ, Small DH. Toxicity of substrate-bound amyloid peptides on vascular smooth muscle cells is enhanced by homocysteine. European Journal of Biochemistry / Febs. 269: 3014-22. PMID 12071966 DOI: 10.1046/j.1432-1033.2002.02976.x  1
2002 Fodero LR, Sáez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. Journal of Neurochemistry. 81: 441-8. PMID 12065653 DOI: 10.1046/j.1471-4159.2002.00902.x  1
2002 Hamilton JA, Whitty G, White AR, Jobling MF, Thompson A, Barrow CJ, Cappai R, Beyreuther K, Masters CL. Alzheimer's disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF). Brain Research. 940: 49-54. PMID 12020874 DOI: 10.1016/S0006-8993(02)02589-1  1
2002 Evin G, Smith MJ, Tziotis A, McLean C, Canterford L, Sharples RA, Cappai R, Weidemann A, Beyreuther K, Cotton RG, Masters CL, Culvenor JG. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Neuroreport. 13: 917-21. PMID 11997713  1
2002 Evin G, Smith MJ, Tziotis A, McLean C, Canterford L, Sharples RA, Cappai R, Weidemann A, Beyreuther K, Cotton RG, Masters CL, Culvenor JG. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Neuroreport. 13: 719-23. PMID 11973477  1
2002 Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, Masters CL, Beyreuther K, Evin G. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry. 41: 2825-35. PMID 11851430 DOI: 10.1021/bi015794o  1
2002 Lichtenthaler SF, Beher D, Grimm HS, Wang R, Shearman MS, Masters CL, Beyreuther K. The intramembrane cleavage site of the amyloid precursor protein depends on the length of its transmembrane domain. Proceedings of the National Academy of Sciences of the United States of America. 99: 1365-70. PMID 11805291 DOI: 10.1073/pnas.032395699  1
2002 White AR, Multhaup G, Galatis D, McKinstry WJ, Parker MW, Pipkorn R, Beyreuther K, Masters CL, Cappai R. Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 365-76. PMID 11784781  1
2001 Masters CL, Beyreuther K. Henryk M. Wisniewski and the amyloid theory of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 3: 83-86. PMID 12214076  1
2001 McLean CA, Beyreuther K, Masters CL. Amyloid Abeta levels in Alzheimer's disease - A diagnostic tool and the key to understanding the natural history of Abeta? Journal of Alzheimer's Disease : Jad. 3: 305-312. PMID 12214051  1
1999 Small DH, Clarris HL, Williamson TG, Reed G, Key B, Mok SS, Beyreuther K, Masters CL, Nurcombe V. Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 1: 275-85. PMID 12214125  1
Show low-probability matches.